Table Of Content

Author Index to Volume 21 Ahern MJ, 303 Chan W, 25 Fox RM, 875 Hobbin ER, 230 Ahern MJ, 844 Chang L, 433 Foy SG, 335 Hobbs MST, 681 Allan TM, 487 Chapman JR, 693 Frasca J, 739 Holdsworth RF, 43 Alpers JH, 217 Cheng TO, 82 Fraser I, 418 Hogan P, 341 Alvarez J, 891 Cistulli PA, 246 Fraser A, 769 Hollingsworth P, 844 Ambridge MA, 78 Clancy RL, 222 Freitas E, 881 Hong J, 307 Ambrogetti A, 863 Clark M, 303 Friedlander Y, 330, 701 Horowitz M, 275, 488 Andrews GR, 230 Cleghorn DB, 275 Friedman P, 290, 487 Hoy J, 747 Armstrong JG, 879 Cleland LG, 444 Frost T, 293 Hudgson P, 381 Ashby M, 850 Collins S, 837 Froudist JH, 871 Hughes CF, 211 Gallicchio M, 433, 867 Hunt D, 25 Atkinson K, 686, 850 Concannon A, 850 Gallus AS, 319 Ianseh R, 314 Bailey BP, 211 Cooper IA, 16, 489 Garsia RJ, 380 Ihle B, 418 Baker C, 867 Cosh DG, 319 Gates P, 732 Ikram H, 335 Balasubramaniam S, 330 Cowen AE, 439 Gebski V, 427 Ingham HR, 381 Barnes DJ, 246 Cox SV, 401, 931 Genge S, 82 Irving L, 4 Barr AE, 227 Craig PI, 387 George J, 356, 379 Iyer PV, 49 Barter PJ, 299 Crane J, 753 George PM, 485 Jean-Francois B, 837 Bartlett PF, 477 Crewe E, 22 Gill JS, 457 Jeremy R, 82 Basser RL, 875 Cripps AW, 222 Gill MC, 720 Jones G, 80 Bastian I, 739 Crockett AJ, 217 Gillies AHB, 414 Joske DJL, 62 Batey RG, 387 Crozier IG, 335 Gillon RL, 871 Juttner C, 686 Baumgart KW, 380 Cruickshank D, 16 Goadsby PJ, 930 Kalman JM, 744 Bayliss C, 844 Cunningham A, 22 Gonczi J, 723 Kay RLC, 751 Beasley R, 753 Dale B, 686 Goodheart RS, 339 Kefford RF, 857 BBBBeieergenngtssssot onenJ i CnE, R, , L6 3,820 617,21 1 18 50 DDDDeaaeavv liiW ss yCtMLWtJM, E, C, N 8,92163 29 2 48 GGGGrrrraeaacechenea ym J M,MD J,4,S4 , 7 9 281171 5 KKKKKieeeellnmnpltpnay set trdSBieJy,c,r k 77I84PCT17,SJ ,, 3 143473,75 732 Grey AB, 442 Bilous M, 387 Dean AP, 47, 783 Kincaid-Smith P, 418, 726 Grierson J, 387 Bird DM, 714 Dennett X, 837 Kirkland MA, 739 Grimes D, 835 Blumbergs PC, 49 Dewar J, 460 Gyulay S, 291 Knight JL, 681 Bonaventura A, 244 Dietzsch E, 307 Hallpike JF, 49 Knight P, 239 Bond MJ, 230 Ding JC, 16, 489 Hamilton I, 769 Krilis SA, 463 Bosco J, 454 Dodds A, 850 Hannan T, 363, 781 Kuchar D, 451 Bowman PK, 78 Doecke CJ, 319 Harper R, 325 Lai FM, 751 Bradley J, 844 Douglas AS, 487 Harrington T, 737 Laing B, 844 Lake FR, 871 Bradstock K, 686 Downs K, 686, 850 Harris DCH, 22, 693 Lane MR, 769, 884 Bremer JM, 422 Dunne JW, 339 Harris MG, 230 Larkins RG, 675 Brennan JB, 744 Durbridge TC, 275 Harris RD, 230, 784 Larmour I, 314 Brennan FN, 439 Edis RH, 339, 886, 929 Harris S, 353 Lau Kai-chiu, 239 Broughton A, 325 Edmunds SEJ, 345 Harrison W’, 844 Laurence BH, 439 Brown MA, 257 Ehrlich F, 783 Hatfield PJ, 29 Lawrence S, 82, 693 Brown NN, 227 Eisman JA, 205 Hazelton RA, 343 Ledingham JGG, 893 Bulling MT, 397 Evans PR, 58 Heathcote P, 780 Lee MK, 772 Burgess C, 753 Evans RA, 488 Heaton DC, 485 Leslie DE, 307 Burns RJ, 397 Evans S, 52 Heller FR, 292 Lethlean AK, 350 Burrow JN, 49 Fairley CK, 747 Heller R, 701 Lichtenstein M, 25 Byrne E, 732, 837 Farrell GC, 356, 387 Hely MA, 82 Lieschke GJ, 875 Calafiore P, 744 Fatkin D, 451 Henderson A, 742 Liew KH, 16, 489 Henderson D, 353 Lin R, 387 Cameron DP, 714 Feather IR, 7 Henderson JM, 11 Lintott CJ, 422 Cameron S, 65 Feldheim J, 65 Henrion J, 291 Lockwood CM, 36 Campbell E, 393 Fellowes AP, 485 Henschke PJ, 230 Longdon P, 742 Celermajer DS, 211 Firouz-Abadi AA, 881 Hensley MJ, 222 Low CJS, 335 Chakravarty BJ, 769, 844 Firth JD, 893 Hickie JB, 330, 451 Lowenthal RM, 686 Chalk JB, 379 Fisher M, 29 Hickman PE, 291 Lubicz S, 744 Chalmers JP, 230, 281 Flecknoe-Brown S, 81 Hill PT, 242 Ma A, 714 Champion G, 230 Fox JP, 881 Hirst F, 931 MacD. Agar JW, 784 INDEX TO AUTHORS - VOL. 21; 1991 Macdonald G, 1 Nordin BEC, 275, 488 Sanson-Fisher R, 393 Thyagarajan D, 837 Malcolm D, 774 O’Brien KP, 230 Saunders NA, 222, 235, 863 Tiver KW, 857 Manoharan A, 405 O’Connell D, 80 Savige JA, 36, 433, 720, 867 Toh B Hock, 307 Mansberg R, 52, 55 O’Sullivan RA, 879 Schapira M, 292 Tonkin A, 230 Marshall E, 780 Olson LG, 7, 235, 291, 863 Schoeman MN, 387 Trent RJ, 447 Martin L, 307 Page M, 928 Schultz D, 303 Tribe AE, 871 Marzuki S, 837 Palmer KR, 888 Scicchitano R, 222 Trotter JM, 780 Mashford ML, 491 Panayiotou BN, 348 Scott RS, 422 Truswell AS, 931 Turnbull RJ, 230 McAleer R, 871 Pang SC, 457 Seale JP, 678 Uther JB, 239 McCallum J, 701 Parkin L, 227 Shardey GC, 325 Van der Weyden MB, 43 McCaughan B, 447 Parkin JD, 433 Shenfield GM, 928 Varigos G, 867 McCluskey J, 307 Paterson CA, 714 Sheridan WP, 408, 875 Vecchio P, 343 McCombe PA, 227, 379 Pathmanathan R, 454 Shilkin KB, 251, 460 Vernon-Roberts E, 744 McDonald JA, 387 Paton DM, 80 Shine J, 330 Vohra JK, 25 McGiffin DC, 881 Pearce N, 753 Shirlaw TM, 335 Walker C, 65 McGill NW, 710 Pedersen JS, 43 Silbert PL, 886, 929 Walpole ET, 835 McGuire MA, 239 Pender MP, 379 Simons J, 330, 701 Walsh B, 222 Mcintyre HD, 714 Perera DM, 681 Simons LA, 330, 701 Ward M, 379 McKenzie T, 251 Pierce RJ, 4, 833, 917 Simpson FO, 290 Warren RJ, 25 McLaughlin AF, 447, 489 Popplewell PY, 230 Simpson IJ, 442 West MJ. 881 McNeil HP, 463 Potter JM, 291 Singh GP, 931 West PD, 248 McNeil JD, 444 Wetzig N, 341 Powell I, 701 Skerritt JH, 723 Metcalf C, 780 Whelan G, 71 Prince M, 43 Soden M, 303 Mijch A, 747 Whitaker D, 460 Quin JW, 380 Stafford B, 293, 782 Mitchell CA, 879 Whitby M, 341, 780 Mitchell H, 764 Quinlan MF, 251 Stanley D, 353 Whyte G, 43 Mitchell JD, 723 Quong GG, 16, 489 Stepanas AV, 242 Wilkinson ML, 345 Mohamed KN, 290 Radford AJ, 230 Stewart AM, 230 Williams AJK, 888 Mond HG, 25 Ravenscroft PJ, 714 Stewart JF, 244 Williams BG, 447 Morris HA, 275 Reed WD, 47, 251, 783 Stewart JH, 693 Wilson A, 732 Morris JGL, 11, 82 Rivers JT, 879 Stiller KR, 78 Wilson F, 850 Moss JR, 217 Roberts L, 780 Stock H, 681 Wilton NM, 491 Morrison RBI, 29 Roder D, 65 Strakosch CR, 248 Windom H, 753 Mossman S, 930 Roger SD, 22, 693 Street A, 747 Wing LMH, 397 Muller D, 325 Rolfe I, 235 Stuart-Harris RC, 857 Wing YK, 751 Munn §S, 884 Rolland J, 307 Sutherland DC, 222 Wolf MM, 16, 489 Murray B, 52 Rosenfeld JV, 477 Szanto A, 330 Wood G, 341, 780 Woodhouse S, 401 Musk AW, 460, 681 Rosenfeldt FL, 325 Szer J, 43, 408, 686 Wrigley C, 222 Nagaratnam N, 381 Rosenthal MA, 857 Tandon MK, 427 Yiannikas C, 11 Nankivell BJ, 414 Ross DL, 239 Tannenberg AEG, 379 Yip M-Y, 55 Nash P, 737 Rowlings PA, 52, 55 Thomas MG, 442 York HF, 710 Naughton M, 833, 917 Rozenberg MC, 52, 55 Thompson PJ, 871 Young GAR, 246, 447 Neale TJ, 29 Ruhno J, 222 Thompson TJ, 29 Young GD, 444 Need AG, 275, 488 Russell D, 487 Thomson DB, 835 Young S, 850 Ng K, 886 Ryan G, 681 Thomson K, 902 Zagami AS, 350 Ng SC, 772 Sallie RW, 251 Thorburn C, 451 Zeng GE, 211 INDEX TO AUTHORS —- VOL. 21; 1991 Subject Index to Volume 21 Aboriginal children, Australian, nutrition and infections in, 921 Aspirin, effects of, on the healing of duodenal ulcer, ethical aspects Aborigine, adult T-cell leukaemia lymphoma in an, 739 of a study of (Letter), 80 Actinomycosis, pulmonary, complicated by effusive constrictive Asterixis with carbamazepine toxicity, complete external pericarditis, 879 ophthalmoplegia and, 886 Adenocarcinoma, pancreatic, responding to cisplatin based cytotoxic Asthma Campaign, the National — a measurable public health chemotherapy (Letter), 780 exercise (Editorial), 4 AIDS, invasive aspergillosis in, 747 Asthma deaths: where are we now? (Editorial), 678 Alpha 1-antitrypsin deficiency and pancreatitis in a juvenile, 345 Asthma, risk factors for death in patients admitted to hospital with: Alpha thalassaemia and hereditary spherocytosis, concurrence of, 485 a follow-up study, 681 Alpha-2b interferon, recombinant, in patients with malignant Asthma mortality and inhaled beta agonist therapy, 753 carcinoid tumour, 875 Atrioventricular junction ablation, direct-current shock, ventricular Alpha-interferon, relief of itch associated with myeloproliferative dysfunction following, 25 disease by (Letter), 81 Autoantibodies in systemic vasculitis, 433 Amyloid arthropathy of the shoulder, spontaneous haemarthrosis Azathioprine and cyclosporin in refractory rheumatoid arthritis, in, 343 randomised double blind trial of, 844 Anaemia, severe aplastic, cyclosporin associated remission (Letter), 292 Angioplasty, coronary, emergency coronary artery bypass surgery Barmah Forest polyarthritis, acute, 737 following — favourable medium term outcome after eight years’ Beta agonist, inhaled, therapy, asthma mortality and, 753 experience, 211 Biochemical and molecular investigation of mitochondrial disease: Anti-GBM antibody-mediated disease, human, inability to detect an illustrative case showing the value of a multifaceted approach, circulating anti-idiotypic antibodies in, using a splenic PFC assay, 837 36 Bipolaris and Curvularia, allergic bronchopulmonary fungal disease Anti-gliadin antibodies in serum, enzyme-linked immunosorbent caused by, 871 assay to detect: a reliable screening test for coeliac disease, 723 Blood pressure and body mass index in obstructive sleep apnoea, Anti-idiotypic antibodies, circulating, in human anti-GBM antibody- effects of nasal continuous positive airway pressure on, 917 mediated disease, inability to detect, using a splenic PFC assay, 36 Bone marrow transplantation, allogeneic, GM-CSF after: accelerated Antibodies, antiphospholipid, 463 recovery of neutrophils, monocytes and lymphocytes, 686 Antibodies, circulating anti-idiotypic, in human anti-GBM antibody- Bone marrow transplantation, allogeneic, from histocompatible mediated disease, inability to detect, using a splenic PFC assay, 36 sibling donors, chronic myeloid leukaemia treated by — an Antibodies, anti-gliadin, in serum, enzyme-linked immunosorbent invariably fatal malignancy rendered highly curable, 408 assay to detect: a reliable screening test for coeliac disease, 723 Bromocriptine therapy, retroperitoneal fibrosis, skin and pleuropul- Antiphospholipid antibodies, 463 monary changes associated with (Letter), 82 Antithrombin III deficiency, cerebral venous thrombosis associated Bronchospasm, frusemide antagonises exercise-induced but not with, 772 histamine-induced, 7 Antithymocyte-globulin and corticosteroid therapy, response to: trans- fusion associated graft-versus-host disease after cardiac surgery, 43 Apnoea, sleep: contribution to the road toll (Editorial), 833 Calcium and osteoporosis, 275 Apnoea, obstructive sleep, differences in the symptoms of men and Calcium, osteoporosis and (Letter), 488 women with, 863 Cancer prevention in Australia, the potential for, 764 Apnoea, obstructive sleep, effects of nasal continuous positive airway Cancer, colorectal, what is the risk of developing? — ulcerative colitis, pressure on blood pressure and body mass index in, 917 71 Apnoea, obstructive sleep, long-term nasal CPAP does not ameliorate, Carbamazepine toxicity, complete external ophthalmoplegia and 235 asterixis with, 886 Apo A-I and coronary artery disease, high density lipoproteins, genetic Carbidopa/levodopa, controlled release, (Sinemet CR4), in polymorphism for, 330 Parkinson’s disease — an open evaluation of efficacy and safety, Apomorphine injection, intermittent subcutaneous, treatment for 397 Parkinsonian motor oscillations, 314 Carcinoid tumour, malignant, recombinant alpha-2b interferon in Arrhythmogenic right ventricular dysplasia, 451 patients with, 875 Arteritis, giant cell, associated with pericarditis and large vessel Carcinoma, transitional cell, of the renal pelvis, complete response disease, 353 of a, to leucovorin/5 fluorouracil chemotherapy, 244 Arteritis, giant cell, in two Chinese patients, 751 Cardiac papillary fibroelastomas, multiple, and rheumatic heart Arteritis, giant cell, ophthalmoplegia and (Letter), 930 disease, 744 Artery, left main coronary, spontaneous dissection of the: case report Cardiac surgery, transfusion associated graft-versus-host disease after: and review of the literature, 891 response to antithymocyte-globulin and corticosteroid therapy, 43 Arthropathy, amyloid, of the shoulder, spontaneous haemarthrosis Cardiac surgery, painful sciatic neuropathy following, 732 in, 343 ‘Cardiomyopathy’, permanent junctional reciprocating tachycardia Arthur E. Mills Oration, the — self-regulation and the professions: misdiagnosed as, 239 continuing legal education and regulating the regulators, 774 Cardiovascular and sociological risk factors at entry: Dubbo study Aspergillosis, invasive, in AIDS, 747 of the elderly, 701 Aspirin concurrently administered with ranitidine does not delay Castleman’s disease, POEMS syndrome and osteosclerotic myeloma: healing of duodenal ulcer (Letter), 80 a case report, 454 SUBJECT INDEX — VOL. 21, 1991 973 Cerebral infarction, progressive: Kohlmeier-Degos disease, a CPAP machines, nasal, problems with (Letter), 291 multisystem vasculopathy with, 49 Cronkhite-Canada syndrome associated with peripheral neuropathy Cerebral venous thrombosis associated with antithrombin III (Letter), 379 deficiency, 772 Cryofribrinogenaemia: a case report, 444 Cerebral artery infarction, right anterior, post-hemiplegic dystonia Crystals, reproducibility of synovial fluid examination for, 710 following (Letter), 381 Curvularia and Bipolaris, allergic bronchopulmonary fungal disease Cerebrospinal fluid, monoclonal immunoglobulin bands in the, 227 caused by, 871 Cerebrovascular accident, left, inability to cough voluntarily following Cutaneous lymphoma, an unusual, with B and T cell characteristics a, 78 showing gallium-67 positive benign thymic hyperplasia following Chemotherapy, cytotoxic, cisplatin based, pancreatic adenocarcinoma intensive chemotherapy, 447 responding to (Letter), 780 Cyclosporin A and mefenamic acid in a renal transplant patient Chemotherapy, intensive, an unusual cutaneous lymphoma with B (Letter), 784 and T cell characteristics showing gallium-67 positive benign Cyclosporin associated remission in severe aplastic anaemia (Letter), thymic hyperplasia following, 447 292 Chinese patients, two, giant cell arteritis in, 751 Cyclosporin and azathioprine in refractory rheumatoid arthritis, Chinese, pathology of fatal acute myocardial infarction in the (Letter), randomised double blind trial of, 844 82 Cyclosporin and methotrexate versus cyclosporin, methotrexate and Cholesterol, screening and intervention for (Editorial), 393 prednisolone for prevention of graft-versus-host disease after Cholesterol reduction, oat bran and: evidence against specific effect, HLA-identical sibling marrow transplantation for haematological 422 malignancy, a prospective randomised trial oi, 850 Cholesterol emboli, renal failure due to, 418 Cytochromes P450, human hepatic, role of, in drug metabolism and Chorioretinitis as a possible very early manifestation of subacute toxicity, 356 sclerosing panencephalitis, 350 Cytotoxic chemotherapy, cisplatin based, pancreatic adenocarcinoma Chronic bronchitis, acute exacerbations of, a controlled trial of a responding to (Letter), 780 killed Haemophilus influenzae vaccine for prevention of, 427 Chronic myeloid leukaemia treated by allogeneic bone marrow trans- plantation from histocompatible sibling donors — an invariably Dantrolene, intravenous, fulminant metoclopramide induced fatal malignancy rendered highly curable, 408 neuroleptic malignant syndrome rapidly responsive to, 742 Cisplatin based cytotoxic chemotherapy, pancreatic adenocarcinoma Diabetes mellitus, Type 2 (non-insulin dependent), metformin responding to (Letter), 780 increases insulin sensitivity and basal glucose clearance in, 714 Coeliac plexus blockade, more complications of (Letter), 782 Diabetes mellitus and pancreatitis, pentamidine induced, survival Coeliac disease, a reliable screening test for: enzyme-linked from, 341 immunosorbent assay to detect anti-gliadin antibodies in serum, Diabetes mellitus and optic disc oedema: a case report with review, 723 248 Coeliac disease and epidermolysis bullosa acquisita, circulating anti- Diabetic end stage renal failure — the Wellington experience glomerular basement membrane antibodies in, 867 1975-1988, 29 Coeliac plexus block — diarrhoea, an unrecognised hazard of, 47 Diarrhoea — an unrecognised hazard of coeliac plexus block, 47 Colonoscopy, a randomised blinded study in colonic lavage for, 769 Diclofenac hepatitis, 251 Colorectal cancer, what is the risk of developing? — ulcerative colitis, Drug metabolism and toxicity, role of human hepatic cytochromes 71 P450 in, 356 Constipation, severe, as the presenting complaint of phaeochromo- Drug, multi-, resistant tuberculosis in migrants, 457 cytoma, 888 Duodenal ulcer, ethical aspects of a study of the effects of aspirin Continuous positive airway pressure (CPAP), long-term nasal, does on the healing of (Letter), 80 not ameliorate obstructive sleep apnoea, 235 Duodenal ulcer, aspirin concurrently administered with ranitidine Continuous positive airway pressure (CPAP), nasal, problems with does not delay healing of (Letter), 80 (Letter), 291 Dystonia, post-hemiplegic, following right anterior cerebral artery Coronary care unit, screening for hypercholesterolaemia in a (Letter), infarction (Letter), 381 931 Coronary heart disease, high density lipoproteins and (Editorial), 299 Coronary artery disease and apo A-I, high density lipoproteins, Elderly, Dubbo study of the: sociological and cardiovascular risk genetic polymorphism for, 330 factors at entry, 701 Coronary care unit, physician response to screening for hyper- Elderly patients, acutely ill, a defined group of, managed in a geriatric cholesterolaemia in, 401 assessment unit or a general medical unit, a randomised study Coronary angioplasty, emergency coronary artery bypass surgery of outcomes in, 230 following — favourable medium term outcome after eight years’ Empyema, salmonella, in a patient with lymphoma, 246 experience, 211 Endovascular infection, Sa/monella hadar, cure of, with medical Coronary artery bypass surgery, emergency, following coronary therapy, 442 angioplasty — favourable medium term outcome after eight years’ Eosinophilia and pulmonary infiltrates associated with sulphasalazine experience, 211 administration, 348 Corticosteroid and antithymocyte-globulin therapy, response to: trans- Epidemiological characteristics of Legionella infection in South fusion associated graft-versus-host disease after cardiac surgery, 43 Australia: implications for disease control, 65 Cotrimoxazole, Pneumocystis carinii pneumonia — upper lobe recur- Epidermolysis bullosa acquisita, circulating anti-glomerular basement rence following (Letter), 380 membrane antibodies in coeliac disease and, 867 Cough, chronic, an unusual case of (Letter), 780 Epilepsy, temporal lobe, sino-atrial arrest due to, 62 Cough voluntarily, inability to, following a left cerebrovascular Eruption, extensive fixed, to mefenamic acid (Letter), 290 accident, 78 Erythropoietin, low dose, in maintenance haemodialysis: CPAP, long-term nasal, does not ameliorate obstructive sleep apnoea, improvement in quality of life and reduction in true cost of 235 haemodialysis, 693 974 SUBJECT INDEX —- VOL. 21, 1991 Ethical aspects of a study of the effects of aspirin on the healing Hepatitis C, chronic active, can the response to interferon treatment of duodenal ulcer (Letter), 80 be predicted in patients with?, 387 Hepatitis, ischaemic . . . or hypoxic (Letter), 291 Hepatitis, diclofenac, 251 High density lipoproteins and coronary heart disease (Editorial), 299 Fibrosis, retroperitoneal, skin and pleuropulmonary changes High density lipoproteins, genetic polymorphism for apo A-I and associated with bromocriptine therapy (Letter), 82 coronary artery disease, 330 5-fluorouracil/leucovorin chemotherapy, complete response of a Histamine-induced bronchospasm, frusemide antagonises exercise- transitional cell carcinoma of the renal pelvis to, 244 induced but not, 7 Frusemide antagonises exercise-induced but not histamine-induced HIV positive patient, first and second complete remission in a, bronchospasm, 7 following remission induction therapy for acute non- Fungal disease, allergic bronchopulmonary, caused by Bipolaris and lymphoblastic leukaemia, 55 Curvularia, 871 Hodgkin’s disease, the place of gallium scanning is established in (Letter), 489 Hodgkin’s disease, infradiaphragmatic, long term follow-up of a rare presentation, 16 Gallium scanning, the place of, in Hodgkin’s disease is established Hypercalcaemia, lithium and (Editorial), 675 (Letter), 489 Hypercholesterolaemia in a coronary care unit, physician response Gallium-67 positive benign thymic hyperplasia following intensive to screening for, 401 chemotherapy, an unusual cutaneous lymphoma with B and T Hypercholesterolaemia in a coronary care unit, screening for (Letter), cell characteristics showing, 447 931 Gene, T cell receptor and immunoglobulin, rearrangement analysis Hypertension, managing (Letter), 290 as a laboratory aid in the diagnosis of human malignant Hypertension, pregnancy-induced: pathogenesis and management, lymphoproliferative diseases, 307 257 Genetic locus, a single, for adult polycystic kidney disease in five Hypoxic . . . or ischaemic hepatitis (Letter), 291 Australian families of southern European origin, 720 Genetic polymorphism, high density lipoproteins for apo A-I and coronary artery disease, 330 Geriatric assessment unit or general medical unit, a randomised study ‘Informatics, medical’— a bridge between the clinician and the of outcomes in a defined group of acutely ill elderly patients computer scientist (Letter), 781 managed in a, 230 Immune thrombocytopenia, targeted-immunosuppression with Giant cell arteritis, status epilepticus with (Letter), 931 vincristine infusion in the treatment of, 405 Giant cell arteritis in two Chinese patients, 751 Immunoglobulin and T cell receptor gene rearrangement analysis Giant cell arteritis associated with pericarditis and large vessel disease, as a laboratory aid in the diagnosis of human malignant 353 lymphoproliferative diseases, 307 GM-CSF after allogeneic bone marrow transplantation: accelerated Immunoglobulin bands, monoclonal, in the cerebrospinal fluid, 227 recovery of neutrophils, monocytes and lymphocytes, 686 Immunosuppression, targeted-, with vincristine infusion in the Graft-versus-host disease after HLA-identical sibling marrow trans- treatment of immune thrombocytopenia, 405 plantation for haematological malignancy, a prospective Infarction, progressive cerebral: Kohlmeier-Degos disease, a randomised trial of cyclosporin and methotrexate versus multisystem vasculopathy with, 49 cyclosporin, methotrexate and prednisolone for prevention of, 850 Infarction, cerebral artery, right anterior, post-hemiplegic dystonia Graft-versus-host disease, transfusion associated, after cardiac surgery: following (Letter), 381 response to antithymocyte-globulin and corticosteroid therapy, 43 Infections in Australian Aboriginal children, nutrition and, 921 Informatics, medical — an Australian perspective, 363 Infradiaphragmatic Hodgkin’s disease, long term follow-up of a rare presentation, 16 Haemangiopericytoma, meningeal, hepatic metastasis from a, 884 Insulin sensitivity and basal glucose clearance in Type 2 (non-insulin Haemarthrosis, spontaneous, in amyloid arthropathy of the shoulder, dependent) diabetes mellitus, metformin increases, 714 343 Interferon treatment, can the response be predicted in patients with Haematological malignancy, HLA-identical sibling marrow trans- chronic active hepatitis C?, 387 plantation for, a prospective randomised trial of cyclosporin and Interferon, recombinant alpha-2b, in patients with malignant methotrexate versus cyclosporin, methotrexate and prednisolone carcinoid tumour, 875 for prevention of graft-versus-host disease after, 850 Interventional radiology — a review 902 Haemodialysis patients, hepatitis C virus infection in, 22 Intoxication, accidental or deliberate, ‘superwarfarins’ as agents of Haemodialysis, maintenance, low dose erythropoietin in: (Letter), 491 improvement in quality of life and reduction in true cost of Ischaemic . . . or hypoxic hepatitis (Letter), 291 haemodialysis, 693 H philus infl , a killed, vaccine for prevention of acute exacerbations of chronic bronchitis, a controlled trial of, 427 Kidney disease, adult polycystic, a single genetic locus for, in five Heparin dependent thrombocytopenia and thrombosis, the use of Australian families of southern European origin, 720 a low molecular weight heparinoid (Org 10172) for extracorporeal Kohlmeier-Degos disease: a multisystem vasculopathy with procedures in patients with, 52 progressive cerebral infarction, 49 Heparinoid, low molecular weight (Org 10172), the use of a, for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis, 52 Hepatic metastasis from a meningeal haemangiopericytoma, 884 Lambie-Dew Oration, the, 281 Hepatic cytochromes P450, human, role of, in drug metabolism and Laser, Nd-Yag, endoscopic therapy, successful treatment of two toxicity, 356 patients with gastric antral vascular ectasia ‘watermelon stomach’, Hepatitis C virus infection in haemodialysis patients, 22 439 SUBJECT INDEX — VOL. 21, 1991 975 Legal education, continuing, and regulating the regulators: self- Mydriasis, accidental, due to Prantal powder® (Letter), 929 regulation and the professions. The Arthur E. Mills Oration, 774 Myeloproliferative disease, relief of itch associated with, by alpha- Legionella infection in South Australia, epidemiological charac- interferon (Letter), 81 teristics of: implications for disease control, 65 Myocardial infarction, acute, the early diagnosis of, 335 Leiomyosarcoma, primary, of the heart: a rare cause of obstruction Myocardial infarction, fatal acute, in the Chinese, pathology of of the left ventricular outflow tract, 879 (Letter), 82 Leucovorin/5-fluorouracil chemotherapy, complete response of a transitional cell carcinoma of the renal pelvis to, 244 Leukaemia, chronic myeloid, treated by allogeneic bone marrow Nasal CPAP machines, problems with (Letter), 291 transplantation from histocompatible sibling donors — an National Asthma Campaign, the — a measurable public health invariably fatal malignancy rendered highly curable, 408 exercise (Editorial), 4 Leukaemia, acute non-lymphoblastic, first and second complete Nd-Yag laser therapy, endoscopic, successful treatment of two remissions in a HIV positive patient following remission therapy patients with gastric antral vascular ectasia ‘watermelon stomach’ for, 55 using, 439 Leukaemia lymphoma, adult T-cell, in an Aborigine, 739 Necrobacillosis — primary anaerobic septicaemia (Letter), 381 Levodopa/carbidopa, controlled release, (Sinemet CR4), in Nephrotic syndrome, renal sodium retention in, 893 Parkinson’s disease — an open evaluation of efficacy and safety, Neural transplantation for Parkinson’s disease: a critical appraisal, 477 397 Neuroleptic malignant syndrome, fulminant metoclopramide Lipoproteins, high density, and coronary heart disease (Editorial), 299 induced, rapidly responsive to intravenous dantrolene, 742 Lipoproteins, high density, genetic polymorphism for apo A-I and Neuropathy, peripheral, phenelzine associated — clinical and coronary artery disease, 330 electrophysiologic findings, 339 Lithium and hypercalcaemia (Editorial), 675 Neuropathy, peripheral, Cronkhite-Canada syndrome associated with Low molecular weight heparinoid (Org 10172), the use of a, for extracorporeal procedures in patients with heparin dependent (Letter), 379 thrombocytopenia and thrombosis, 52 Neuropathy, painful sciatic, following cardiac surgery, 732 Lymphoma, an unusual cutaneous, with B and T cell characteristics New Zealand, variation in vascular mortality in (Letter), 487 Non-seminomatous germ cell tumours of the testis: game and set showing gallium-67 positive benign thymic hyperplasia following but not match (Editorial), 835 intensive chemotherapy, 447 Nutrition and infections in Australian Aboriginal children, 921 Lymphoma, salmonella empyema in a patient with, 246 Lymphoproliferative diseases, human malignant, T cell receptor and immunoglobulin gene rearrangement analysis as a laboratory aid in the diagnosis of, 307 Oat bran and cholesterol reduction: evidence against specific effect, 422 Obstruction of the left ventricular outflow tract, primary leiomyosarcoma of the heart: a rare cause of, 881 Oesophageal intramural pseudodiverticulosis — always benign?, 58 Madopar, standard, and controlled release Madopar in Parkinson’s One swallow doth not summer make (Letter), 783 disease, a comparison of, 11 Ophthalmoplegia, complete external, asterixis with carbamazepine Marrow transplantation, HLA-identical sibling, for haematological toxicity, and, 886 malignancy, a prospective randomised trial of cyclosporin and Ophthalmoplegia, giant cell arteritis and (Letter), 930 methotrexate versus cyclosporin, methotrexate and prednisolone Optic disc oedema and diabetes mellitus: a case report with review, for prevention of graft-versus-host disease after, 850 248 Mefenamic acid and cyclosporin A in a renal transplant patient Osteoporosis and calcium, 275 (Letter), 784 Osteoporosis and calcium (Letter), 488 Mefenamic acid, extensive fixed eruption to (Letter), 290 OsteoPPPorosis — Prevention, Prevention and Prevention (Editorial), Meningeal haemangiopericytoma, hepatic metastasis from a, 884 205 Mesothelioma, malignant pleural, miliary spread of, without a Osteosclerotic myeloma, POEMS syndrome and Castleman’s disease: clinically identifiable pleural tumour, 460 a case report, 454 Metastasis, hepatic, from a meningeal haemangiopericytoma, 884 Oxygen therapy, home: an audit of survival, 217 Metformin increases insulin sensitivity and basal glucose clearance in Type 2 (non-insulin dependent) diabetes mellitus, 714 Methotrexate and cyclosporin versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after Pancreatic adenocarcinoma responding to cisplatin based cytotoxic HLA-identical sibling marrow transplantation for haematological chemotherapy (Letter), 780 malignancy, a prospective randomised trial of, 850 Pancreatitis, acute, and rhabdomyolysis: a new association, 414 Metoclopramide induced neuroleptic malignant syndrome, fulminant, Pancreatitis and alpha 1-antitrypsin deficiency in a juvenile, 345 rapidly responsive to intravenous dantrolene, 742 Pancreatitis and diabetes mellitus, pentamidine induced, survival Miconazole oral gel, potentiation of warfarin action by (Letter), 928 from, 341 Migrants, multi-drug resistant tuberculosis in, 457 Panencephalitis, subacute sclerosing, chorioretinitis as a possible very Mitochondrial disease, biochemical and molecular investigation of: early manifestation of, 350 an illustrative case showing the value of a multifaceted approach, Parkinson’s disease, a comparison of standard Madopar and controlled 837 release Madopar in, 11 Molecular and biochemical investigation of mitochondrial disease: Parkinson’s disease, neural transplantation for: a critical appraisal, 477 an illustrative case showing the value of a multifaceted approach, Parkinson’s disease, controlled release levodopa/carbidopa (Sinemet 837 CR4) in — an open evaluation of efficacy and safety, 397 Mortality, vascular, in New Zealand, variation in (Letter), 487 Parkinsonian motor oscillations, intermittent subcutaneous apo- Motor oscillations, Parkinsonian, intermittent subcutaneous apo- morphine injection treatment for, 314 morphine injection treatment for, 314 Pentamidine induced pancreatitis and diabetes mellitus, survival Musculo-skeletal examination, the: a neglected clinical skill, 303 from, 341 976 SUBJECT INDEX —- VOL. 21, 1991 Pericarditis, effusive constrictive, pulmonary actinomycosis com- Sino-atrial arrest due to temporal lobe epilepsy, 62 plicated by, 879 Sleep apnoea, obstructive, long-term nasal CPAP does not ameliorate, Pericarditis and large vessel disease, giant cell arteritis associated 235 with, 353 Sociological and cardiovascular risk factors at entry: Dubbo study Phaeochromocytoma, severe constipation as the presenting complaint of the elderly, 701 of, 888 Sodium retention, renal, in the nephrotic syndrome, 893 Phenelzine associated peripheral neuropathy — clinical and South Australia, epidemiological characteristics of Legionella electrophysiologic findings, 339 infection in: implications for disease control, 65 Plaque-forming cell assay, splenic, inability to detect circulating anti- Southern European origin, five Australian families of, a single genetic idiotypic antibodies in human anti-GBM antibody-mediated locus for adult polycystic kidney disease in, 720 disease using a, 36 Spherocytosis, hereditary, and alpha thalassaemia, concurrence of, Pleuropulmonary and skin changes, retroperitoneal fibrosis associated 485 with bromocriptine therapy (Letter), 82 Spontaneous dissection of the left main artery: case report and review Pneumocystis carinii pneumonia — upper lobe recurrence following of the literature, 891 cotrimoxazole (Letter), 380 Status epilepticus, giant cell arteritis with (Letter), 931 Pneumonia, Pneumocystis carinii — upper lobe recurrence following Subacute sclerosing panencephalitis, chorioretinitis as a possible very cotrimoxazole (Letter), 380 early manifestation of, 350 POEMS syndrome, osteosclerotic myeloma and Castleman’s disease: Sulphasalazine administration, pulmonary infiltrates and eosinophilia a case report, 454 associated with, 348 Polyarthritis, acute Barmah Forest, 737 ‘Superwarfarins’ as agents of accidental or deliberate intoxication Prantal powder® , accidental mydriasis due to (Letter), 929 (Letter), 491 Prednisolone, cyclosporin and methotrexate versus methotrexate and Synovial fluid examination for crystals, reproducibility of, 710 cyclosporin for prevention of graft-versus-host disease after HLA- identical sibling marrow transplantation for haematological malig- nancy, a prospective randomised trial of, 850 Pregnancy-induced hypertension: pathogenesis and management, 257 T and B cell characteristics, an unusual cutaneous lymphoma with, Pseudodiverticulosis, oesophageal intramural — always benign?, 58 showing gallium-67 positive benign thymic hyperplasia following Public health exercise, a measurable — the National Asthma intensive chemotherapy, 447 Campaign (Editorial), 4 T cell receptor and immunoglobulin gene rearrangement analysis Pulmonary actinomycosis complicated by effusive constrictive as a laboratory aid in the diagnosis of human malignant pericarditis, 879 lymphoproliferative diseases, 307 Pulmonary infiltrates and eosinophilia associated with sulphasalazine Tachycardia, permanent junctional reciprocating, misdiagnosed as administration, 348 ‘cardiomyopathy’, 239 Targeted-i ppression with vincristine infusion in the treatment of immune thrombocytopenia, 405 Temporal lobe epilepsy, sino-atrial arrest due to, 62 Radiology, interventional — a review, 902 Testis, non-seminomatous germ cell tumours: game and set but not Ranitidine, concurrently administered with aspirin, does not delay match (Editorial), 835 healing of duodenal ulcer (Letter), 80 Testis, non-seminomatous germ cell tumours, single institutional Recombinant alpha-2b interferon in patients with malignant carcinoid experience with: local perspectives on a curable cancer, 857 tumour, 875 Thalassaemia, alpha, and hereditary spherocytosis, concurrence of, Regulation, self-, and the professions: continuing legal education and 485 regulating the regulators. The Arthur E. Mills Oration, 774 The way we live now (Editorial), 1 Remission induction therapy for acute non-lymphoblastic leukaemia, Thrombocytopenia, immune, targeted-i ppression with first and second complete remissions in a HIV patient following, vincristine infusion in the treatment of, 405 55 Thrombocytopenia and thrombosis, heparin dependent, the use of Renal failure, diabetic end stage — the Wellington experience a low molecular weight heparinoid (Org 10172) for extracorporeal 1975-1988, 29 procedures in patients with, 52 Renal sodium retention in the nephrotic syndrome, 893 Thrombosis, cerebral venous, associated with antithrombin III Renal pelvis, complete response of a transitional cell carcinoma of deficiency, 772 the, to leucovorin/5 fluorouracil chemotherapy, 244 Thrombosis and thrombocytopenia, heparin dependent, the use of Renal transplant patient, cyclosporin A and mefenamic acid in a a low molecular weight heparinoid (Org 10172) for extracorporeal (Letter), 784 procedures in patients with, 52 Renal failure due to cholesterol emboli, 418 Thymic hyperplasia, gallium-67 positive benign, following intensive Respiratory disease, wheat dust-associated, in a farming community, chemotherapy, an unusual cutaneous lymphoma with B and T 222 cell characteristics showing, 447 Rhabdomyolysis, acute pancreatitis and: a new association, 414 Transfusion associated graft-versus-host disease after cardiac surgery: Rheumatic heart disease, multiple cardiac papillary fibroelastomas response to antithymocyte-globulin and corticosteroid therapy, 43 and, 744 Transitional cell carcinoma of the renal pelvis, complete response Rheumatoid arthritis, refractory, a randomised double blind trial of a, to leucovorin/5 fluorouracil chemotherapy, 244 of cyclosporin and azathioprine in, 844 Transplant patient, renal, cyclosporin A and mefenamic acid in a Road toll, sleep apnoea’s contribution to the (Editorial), 833 (Letter), 784 Transplantation, neural, for Parkinson’s disease: a critical appraisal, 477 Salmonella empyema in a patient with lymphoma, 246 Transplantation, allogeneic bone marrow, from histocompatible Salmonella hadar endovascular infection, cure of, with medical sibling donors, chronic myeloid leukaemia treated by — an therapy, 442 invariably fatal malignancy rendered highly curable, 408 Sciatic neuropathy, painful, following cardiac surgery, 732 Transplantation, allogeneic bone marrow, GM-CSF after: accelerated Septicaemia, primary anaerobic - necrobacillosis (Letter), 381 recovery of neutrophils, monocytes and lymphocytes, 686 SUBJECT INDEX —- VOL. 21, 1991 977 Transplantation, HLA-identical sibling marrow, for haematological Vincristine infusion in the treatment of immune thrombocytopenia, malignancy, a prospective randomised trial of cyclosporin and targeted-immunosuppression with, 405 methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after, 850 Tuberculosis, multi-drug resistant, in migrants, 457 Warfarin treatment, standardised initial: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin Ulcerative colitis — what is the risk of developing colorectal cancer?, response, 319 71 Warfarin action, potentiation of, by miconazole oral gel, 928 Warfarin action by miconazole oral gel, potentiation of, 928 ‘Watermelon stomach’, gastric antral vascular ectasia, successful Vascular mortality in New Zealand, variation in (Letter), 487 treatment of two patients with, using endoscopic Nd-YAG laser Vascular ectasia, gastric antral, ‘watermelon stomach’, successful therapy, 439 treatment of two patients with, using endoscopic Nd-YAG laser Wellington experience 1975-1988, the — diabetic end stage renal therapy, 439 failure, 29 Vasculitis, systemic, autoantibodies in, 433 Wheat dust-associated respiratory disease in a farming community, Vasculopathy, a multisystem, with progressive cerebral infarction: 222 Kohlmeier-Degos disease, 49 Wolff-Parkinson-White syndrome, early and late results of surgery Ventricular outflow tract, left, primary leiomyosarcoma of the heart: for, 325 a rare cause of obstruction of the, 881 Ventricular dysfunction following direct-current shock atrio- ventricular junction ablation, 25 Ventricular dysplasia, arrhythmogenic right, 451 XY female athlete with Olympic potential, 242 SUBJECT INDEX - VOL. 21, 1991 Author Index to Proceedings of Special Societies — Volume 21 *Presenters are asterisked. Abbati D, 624, 626* Angus JA, 549 Bailey BP, 513 (four), 514 Beattie L, 611 Abbott D, 811*, 822* Angus PW, 569, 588 (two), 518, 532, 533, 535 Beeney LJ, 794*, 827 Abbott GD, 136 Angus-Leppan H, 602*, 612* (three) Begley CG, 129*, 159, 942*, Abdool I, 594 Anstey NM, 591* Bailey DL, 630 943 Abernethy MJ, 531, 555* Anthony JC, 173 Bailey RR, 135, 516 Begley G, 937, 938 Abeywardena MY, 624 Anthony M, 172*, 602* Bailly D, 122 Beilby J, 819 Ablett G, 145 Antic R, 644, 668 Bainbridge RM, 643 Beilin LJ, 516* Abramson M, 650*, 650, 668, Antico V, 640 Baird A, 599*, 603, 631 Bell AJ, 542 670 Antonino A, 629 Baird RW, 588, 594* Bell CJ, 565*, 571* Ackery D, 524 Antonio M, 534 Baker BW, 136* Bell D, 944 Adams JM, 948 Antoniou D, 565 Baker G, 646* Bell JM, 594, 595 Adena MM, 165 Antony G, 113 Baker J, 831 Bell MC, 196* Adler JS, 183 Antony JH, 174 Baker JJ, 940 Bell SC, 653*, 655* Agar NS, 957* Anvari M, 559* (four), 560* Baker MS, 563, 566, 579* Bellen JC, 629 Agrawal SK, 506 Baker R, 573, 961* Bellomo R, 651*, 658 Apicella C, 670* Ahern M, 187, 191, 195 Baldas J, 628 Bellon MS, 631 Aranki SF, 523 Ahuja GK, 201 Baldwin J, 802, 806*, 821, Belushkina NN, 509 Arbor A, 194 Aitken PM, 101 827*, 829 (two) Benatar SR, 664 Archer JR, 187 Akdeniz A, 793, 814 Balemi A, 671 Bendall LJ, 142, 955 Akkermans LMA, 560, 572, Ardakani B, 617 Ballantyne CL, 189 Beng C, 108* 578 Arkles B, 192 Ballard FJ, 564 Benjelloun H, 523 Al-Aska AK, 203 Arkles LB, 623 Bananis T, 164 Bennett A, 942 Al-Noza M, 203 Armour CL, 647 Bannister KM, 631*, 633* Bennett H, 173, 608 Al-Orainey IA, 203 Armstrong JMcD, 188 Ea:din PG, 647 Bennett N, 825* Alexander T, 811, 826, 827 Armstrong L, 646 Barker G, 547 (two) Bennett P, 194 Alexeyeff M, 564 Armstrong M, 963 Barlow AJ, 556* Bennett SI, 517 Alford FP, 99, 100, 101, 114, Armstrong S, 196 Barnden LR,624* Benson E, 543 792, 793, 807, 813, 817, Arnold B, 134 Barnes RK, 623 Bentley JS, 639* 818, 831 Arnold JMO, 537 Barnett LD, 798 Beran RG, 618, 620*, 621 Alford J, 108* Arnold M, 188 Barnett M, 808* Berbari EJ, 505 Allan RM, 521, 522 (three) Arnold R, 121 Baron D, 543 548 Berend N, 662, 665, 670, Allen DH, 655 Arnott J, 648* Barr TJ, 669, 674 670* Allen J, 581 Aroney CN, 510*, 510, 529 Barter P, 529 Beretov J, 811* Allen JR, 160 Arthur CK, 157, 160, 939, Bartholomeusz RK, 113* Berger H, 152 Allen P, 92 946, 947 Barton H, 629* Bergin B, 549 Allen R, 108 Asbahr H, 949, 953 Bartrop R, 520 Bergin P, 530, 543 Allen RDM, 805* Ashwell S, 120, 795 Bashford J, 139, 951* Berkovic SF, 166*, 177*, Allen RJ, 561* Atchison M, 192 Basic D, 536, 544*, 582* 178*, 616, 620 (two), 632 Allen RKA, 652* Atkins RC, 673 Basile S, 582 Berman DS, 624 Allen RM, 645* Atkinson K, 154, 945, 949, Baskin D, 791 Berman K, 570 Allen S , 508 951, 952 Bass N, 555 Berndt MC, 139* (two), 142, Allen TJ, 96, 104, 793, 793*, Basten A, 493* 955, 959, 964* Attwood PV, 137 798, 814 Batch JA, 114 Berney N, 830*, 831* Au-Yeung D, 138 Allman K, 625 (two) Batchelor F, 581 Bernstein L, 518, 535 (two) Aumann H, 962 Alouan L, 647 Bateman ED, 664 Bertoncello I, 949* Austin MC, 599, 631, 632 Alpers JH, 657 (two), 671 Batey R, 568 (two), 569*, 574, Besser M, 610 Alvarez J, 520 Avalos BR, 949 577 Best JD, 95*, 99, 100, 792*, Amerena J, 528 Avolio A, 526, 527 Bauman A, 644*, 645, 650* 813 Amis T, 667 Axelsen RA, 576 Bautovich GJ, 518, 519, 623, Bestak R, 535 Amlot P, 188 Ayers B, 831* 625, 638 Bett JHN, 510, 529 Anderson CS, 165*, 166*, Ayling E, 638 Baxley WA, 506 Better N, 623*, 625* 493* Aylward PEG, 540 Baxter AG, 113* Bettridge DB, 142 Anderson KP, 546 Azhar A, 816 Baxter RC, 114, 799*, 809, Betts WH, 509* Anderson N, 197 812 Beynon S, 797 Anderson SD, 644, 670 Baan K, 638 Bayliss C, 187 Beyreuther K, 172 Andrew JH, 595 Bacelj A, 91* Beard MEJ, 136, 155*, 160*, Bhathal PS, 561 Andrews JT, 574, 632 Bach LA, 91, 795, 803, 814 947 Bhatia K, 202 (two) Andrews M, 549 Bacigalupo A, 160 Beasley R, 644, 650, 658, 659, Bhattacharya S, 152 Andrikopoulos S, 99*, 808* Bacon B, 644 661 Bibbo G, 626*, 627 AUTHOR INDEX TO PROCEEDINGS OF SPECIAL SOCIETIES — VOL. 21; 1991 Bickley J, 566 Bowen JA, 941 Brown P, 97, 810 Campbell L, 120, 125, 145 Biddle M, 122, 126, 820* Bowen K, 200 Brown RD, 134*, 135, 146 Campbell LJ, 943, 967* Biegler B, 655 Bowen KM, 811 (two), 147* (two), 938* Campbell LV, 100, 795*, 806, Biggs JC, 154, 945, 949 (two), Bower C, 550* (two), 941 (two), 956 807 951 (two), 952 (three) Bower GD, 649 Brown RIG, 507, 508 (four) Campbell SJ, 135 Bilkington G, 938 Bowes G, 643, 650, 654, 656, Brown T, 568 Campbell TJ, 505 Billson V, 92, 795 659, 668, 669, 670, 674 Bruce DG, 89, 585 Cannell PK, 141*, 144*, 157, Bilous RW, 115 Bowman RV, 672 Bruck K, 633 941 Bird C, 660 Boxall JA, 517, 518 Brumley J, 936 Cannon AD, 506* Bird DM, 806 Boyages S, 830 Brunker P, 582, 585 Cantrill E, 577 Bird PH, 95* Boyd AW, 194, 938, 960 Brusic H, 571 Carlin JB, 597 Birner R, 936 Boyd P, 537* Bryant D, 664 (two), 655* Carr RW, 617 Bishop A, 577 Boyd SJ, 639 Bryce JA, 517* Carroll G, 636 Bishop JF, 130, 153, 658, 659, Bradley BA, 161 Bryson J, 107* Carroll GJ, 192, 196 966 Bradley BM, 171 Bryson JM, 818* Carroll K, 963 Black IW, 521* (two), 522 Bradley J, 187 Buchanan JG, 155 Carroll N, 648, 663, 667, (three), 552* Bradley JA, 510 Buchanan N, 178 671*, 672*, Black JL, 173, 647* Bradley TR, 946 Buchanan RRC, 197, 201* Carroll WM, 167, 177, 184, Blacklock H, 149 Bradstock K, 939, 940, 951, Buckley M, 951 602, 612 Blackstone EH, 536 952 Buffery S, 622 Carter A, 824* Blackwell GG, 523 Brady PW, 653 Bull D, 123 Carter B, 523 Blackwell L, 643 Brancatisano A, 651, 667 Bunce I, 157, 948 Carter M, 550 Bladin CF, 176*, 183* Brand JC, 792, 805* Burdon J, 643*, 655* Cartmill TB, 534, 538 Bladin PF, 166, 178, 611, Brand-Maher CE, 136 Burgess C, 650, 658, 659, 644, Case C, 537 616, 620, 632 Branford AL, 158 661 Casey G, 132 (two) Blair A, 120, 125* Brasch JM, 937 Burgess TR, 115, 791 Casley D, 793 Blair SC, 797, 818 Brassat J, 647 Burgin M, 153 Cassidy, 493* Blake DR, 187 Braun J, 966 Burke C, 584, 611 Castaldi PA, 955 Blake DW, 537* Brawn WJ, 524 Burke D, 612 Caterson ID, 99, 103, 797, Blau G, 826 Brazier D, 610 Burke WM, 655, 664 808, 812, 818 (three) Blaufox MD, 493* Breaden A, 543 Burne JA, 613, 617, 622* Catovsky D, 935*, 950* Bleakley P, 579 Brealey J, 566 Burnet RB, 108*, 123 Caudwell J, 792, 811*, 813 Bleasel AF, 174 Breen KJ, 576 (two) Burns GF, 139, 194 (two) Blennerhassett JB, 158 Bremer JM, 107 Burns RJ, 621 Caughey DE, 189 Blight M, 659, 663 Bremner P, 644, 659, 661 Burns T, 569 Caust J, 658, 659 Block J, 164 Brenton W, 617 Burrow JN, 165* Cebon J, 114, 937 Bloomfield CD, 137*, 140* Breslin ABX, 575, 657, 662, Burry HC, 204* Cejnar M, 519*, 520 (two) Bloomfield P, 630 670 Burstow DJ, 510, 527 Center R, 943, 966 Blum P, 602 Bretland PM, 623*, 631*, Burvill PW, 165 Chakera T, 165 Blumbergs PC, 165, 166, 179 634* Butler RN, 565, 565* Challis DR, 956 (two), 603, 605, 615, 621 Brettell M, 154, 962 Butler SP, 637*, 639 Challis J, 943 (two) Blumer C, 196 Brew BJ, 615*, 618 Butler WJ, 565 Chalmers JP, 549 Bochner F, 509 Bridle TM, 624 Bye A, 177 Chamberlain A, 526, 581 Bogardus C, 91 Brieger DB, 513 (three), 513*, Bye AME, 503 Chambers BR, 175, 176 (two), Bohn D, 547 514 (two), 538* Byrne E, 163, 164, 182, 615 599, 612, 614, 615 Bolton AE, 940(two) Brighthope I, 597 Byrne G, 106, 122*, 126, 825 Chamley L, 195 Bolton T, 96 Brindle W, 626* Byth K, 183, 570 Chan FL, 600, 601 Bonadonna RC, 98 Brisco MJ, 129, 156*, 936 Chan K, 649 Bone C, 823 Broadbent B, 654 Caden MJ, 107*, 805* Chan YW, 601*, 613 Bonnem E, 938, 951 Broadhurst R, 554 (two) Cailes JB, 654* Chandler DC, 163 Bonney M, 796, 817* Brocklebank AM, 156 Cala LA, 173* Chang CM, 600, 606, 621* Bonnyman J, 628* Brodribb TR, 592 Cala SJ, 651*, 666* Chang L, 955 Boorman C, 119, 123, 127, Broe GA, 172 (two), Calafiore P, 539 (two), 540* Chang VP, 510, 511 (two), 827 173*(two), 608 (two), 540 512 (two), 543, 664 (two) Borkman M, 120, 807* Bronstein AM, 614 Calame J, 505 Chapman JR, 160*, 963* Botes D, 200 Brookes SHJ, 564 Calder AL, 542, 542* Chapple M, 160 Boundy KL, 166*, 179, 603*, Brookfield M, 123* Calligeros D, 816 Charalambous D, 959 603, 615*, 618* Brooks B, 803, 822, 825*, 827 Cameron DP, 806 Chard RB, 523, 546 Bourke JP, 541* (two), 546 Brooks PM, 193, 199 Cameron J, 510, 529, 530 Charles P, 940, 946 Bourne AJ, 603, 615 Brookwell R, 966 (two), 530* Charlton B, 91 Bourne G, 539* Brotodihardjo A, 574* Cameron PA, 644 Charnock JS, 624 Bournel AJ, 179 Broughton A, 549 Cameron-Smith D, 817* Chase C, 628 Boutagy J, 155 (two), 944 Browett PJ, 143, 146, 155 Campbell B, 529 Chatterton BE, 558, 573, 624, Boutin C, 547 Brown AH, 525 Campbell DA, 507, 657* 658 629, 632, 632*, 639* Bowden DK, 968 Brown D, 503 Campbell E, 122 Chauhan V, 528 Bowden F, 503 Brown JE, 556 Campbell H, 644 Chee K-Y, 503 * Bowden FJ, 593 Brown JM, 527 Campbell IL, 111 (two), 112, Chen C, 99*, 808*, 812 Bowden JJ, 648* Brown L, 831 113 Chen M, 171 980 AUTHOR INDEX TO PROCEEDINGS OF SPECIAL SOCIETIES — VOL. 21; 1991

ebook img

Australian and New Zealand Journal of Medicine 1991: Vol 21 Index PDF

21 Pages·1991·5.3 MB·English
by  
#periodicals #sim_microfilm #pub_internal-medicine-journal
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Australian and New Zealand Journal of Medicine 1991: Vol 21 Index

Author Index to Volume 21 Ahern MJ, 303 Chan W, 25 Fox RM, 875 Hobbin ER, 230 Ahern MJ, 844 Chang L, 433 Foy SG, 335 Hobbs MST, 681 Allan TM, 487 Chapman JR, 693 Frasca J, 739 Holdsworth RF, 43 Alpers JH, 217 Cheng TO, 82 Fraser I, 418 Hogan P, 341 Alvarez J, 891 Cistulli PA, 246 Fraser A, 769 Hollingsworth P, 844 Ambridge MA, 78 Clancy RL, 222 Freitas E, 881 Hong J, 307 Ambrogetti A, 863 Clark M, 303 Friedlander Y, 330, 701 Horowitz M, 275, 488 Andrews GR, 230 Cleghorn DB, 275 Friedman P, 290, 487 Hoy J, 747 Armstrong JG, 879 Cleland LG, 444 Frost T, 293 Hudgson P, 381 Ashby M, 850 Collins S, 837 Froudist JH, 871 Hughes CF, 211 Gallicchio M, 433, 867 Hunt D, 25 Atkinson K, 686, 850 Concannon A, 850 Gallus AS, 319 Ianseh R, 314 Bailey BP, 211 Cooper IA, 16, 489 Garsia RJ, 380 Ihle B, 418 Baker C, 867 Cosh DG, 319 Gates P, 732 Ikram H, 335 Balasubramaniam S, 330 Cowen AE, 439 Gebski V, 427 Ingham HR, 381 Barnes DJ, 246 Cox SV, 401, 931 Genge S, 82 Irving L, 4 Barr AE, 227 Craig PI, 387 George J, 356, 379 Iyer PV, 49 Barter PJ, 299 Crane J, 753 George PM, 485 Jean-Francois B, 837 Bartlett PF, 477 Crewe E, 22 Gill JS, 457 Jeremy R, 82 Basser RL, 875 Cripps AW, 222 Gill MC, 720 Jones G, 80 Bastian I, 739 Crockett AJ, 217 Gillies AHB, 414 Joske DJL, 62 Batey RG, 387 Crozier IG, 335 Gillon RL, 871 Juttner C, 686 Baumgart KW, 380 Cruickshank D, 16 Goadsby PJ, 930 Kalman JM, 744 Bayliss C, 844 Cunningham A, 22 Gonczi J, 723 Kay RLC, 751 Beasley R, 753 Dale B, 686 Goodheart RS, 339 Kefford RF, 857 BBBBeieergenngtssssot onenJ i CnE, R, , L6 3,820 617,21 1 18 50 DDDDeaaeavv liiW ss yCtMLWtJM, E, C, N 8,92163 29 2 48 GGGGrrrraeaacechenea ym J M,MD J,4,S4 , 7 9 281171 5 KKKKKieeeellnmnpltpnay set trdSBieJy,c,r k 77I84PCT17,SJ ,, 3 143473,75 732 Grey AB, 442 Bilous M, 387 Dean AP, 47, 783 Kincaid-Smith P, 418, 726 Grierson J, 387 Bird DM, 714 Dennett X, 837 Kirkland MA, 739 Grimes D, 835 Blumbergs PC, 49 Dewar J, 460 Gyulay S, 291 Knight JL, 681 Bonaventura A, 244 Dietzsch E, 307 Hallpike JF, 49 Knight P, 239 Bond MJ, 230 Ding JC, 16, 489 Hamilton I, 769 Krilis SA, 463 Bosco J, 454 Dodds A, 850 Hannan T, 363, 781 Kuchar D, 451 Bowman PK, 78 Doecke CJ, 319 Harper R, 325 Lai FM, 751 Bradley J, 844 Douglas AS, 487 Harrington T, 737 Laing B, 844 Lake FR, 871 Bradstock K, 686 Downs K, 686, 850 Harris DCH, 22, 693 Lane MR, 769, 884 Bremer JM, 422 Dunne JW, 339 Harris MG, 230 Larkins RG, 675 Brennan JB, 744 Durbridge TC, 275 Harris RD, 230, 784 Larmour I, 314 Brennan FN, 439 Edis RH, 339, 886, 929 Harris S, 353 Lau Kai-chiu, 239 Broughton A, 325 Edmunds SEJ, 345 Harrison W’, 844 Laurence BH, 439 Brown MA, 257 Ehrlich F, 783 Hatfield PJ, 29 Lawrence S, 82, 693 Brown NN, 227 Eisman JA, 205 Hazelton RA, 343 Ledingham JGG, 893 Bulling MT, 397 Evans PR, 58 Heathcote P, 780 Lee MK, 772 Burgess C, 753 Evans RA, 488 Heaton DC, 485 Leslie DE, 307 Burns RJ, 397 Evans S, 52 Heller FR, 292 Lethlean AK, 350 Burrow JN, 49 Fairley CK, 747 Heller R, 701 Lichtenstein M, 25 Byrne E, 732, 837 Farrell GC, 356, 387 Hely MA, 82 Lieschke GJ, 875 Calafiore P, 744 Fatkin D, 451 Henderson A, 742 Liew KH, 16, 489 Henderson D, 353 Lin R, 387 Cameron DP, 714 Feather IR, 7 Henderson JM, 11 Lintott CJ, 422 Cameron S, 65 Feldheim J, 65 Henrion J, 291 Lockwood CM, 36 Campbell E, 393 Fellowes AP, 485 Henschke PJ, 230 Longdon P, 742 Celermajer DS, 211 Firouz-Abadi AA, 881 Hensley MJ, 222 Low CJS, 335 Chakravarty BJ, 769, 844 Firth JD, 893 Hickie JB, 330, 451 Lowenthal RM, 686 Chalk JB, 379 Fisher M, 29 Hickman PE, 291 Lubicz S, 744 Chalmers JP, 230, 281 Flecknoe-Brown S, 81 Hill PT, 242 Ma A, 714 Champion G, 230 Fox JP, 881 Hirst F, 931 MacD. Agar JW, 784 INDEX TO AUTHORS - VOL. 21; 1991 Macdonald G, 1 Nordin BEC, 275, 488 Sanson-Fisher R, 393 Thyagarajan D, 837 Malcolm D, 774 O’Brien KP, 230 Saunders NA, 222, 235, 863 Tiver KW, 857 Manoharan A, 405 O’Connell D, 80 Savige JA, 36, 433, 720, 867 Toh B Hock, 307 Mansberg R, 52, 55 O’Sullivan RA, 879 Schapira M, 292 Tonkin A, 230 Marshall E, 780 Olson LG, 7, 235, 291, 863 Schoeman MN, 387 Trent RJ, 447 Martin L, 307 Page M, 928 Schultz D, 303 Tribe AE, 871 Marzuki S, 837 Palmer KR, 888 Scicchitano R, 222 Trotter JM, 780 Mashford ML, 491 Panayiotou BN, 348 Scott RS, 422 Truswell AS, 931 Turnbull RJ, 230 McAleer R, 871 Pang SC, 457 Seale JP, 678 Uther JB, 239 McCallum J, 701 Parkin L, 227 Shardey GC, 325 Van der Weyden MB, 43 McCaughan B, 447 Parkin JD, 433 Shenfield GM, 928 Varigos G, 867 McCluskey J, 307 Paterson CA, 714 Sheridan WP, 408, 875 Vecchio P, 343 McCombe PA, 227, 379 Pathmanathan R, 454 Shilkin KB, 251, 460 Vernon-Roberts E, 744 McDonald JA, 387 Paton DM, 80 Shine J, 330 Vohra JK, 25 McGiffin DC, 881 Pearce N, 753 Shirlaw TM, 335 Walker C, 65 McGill NW, 710 Pedersen JS, 43 Silbert PL, 886, 929 Walpole ET, 835 McGuire MA, 239 Pender MP, 379 Simons J, 330, 701 Walsh B, 222 Mcintyre HD, 714 Perera DM, 681 Simons LA, 330, 701 Ward M, 379 McKenzie T, 251 Pierce RJ, 4, 833, 917 Simpson FO, 290 Warren RJ, 25 McLaughlin AF, 447, 489 Popplewell PY, 230 Simpson IJ, 442 West MJ. 881 McNeil HP, 463 Potter JM, 291 Singh GP, 931 West PD, 248 McNeil JD, 444 Wetzig N, 341 Powell I, 701 Skerritt JH, 723 Metcalf C, 780 Whelan G, 71 Prince M, 43 Soden M, 303 Mijch A, 747 Whitaker D, 460 Quin JW, 380 Stafford B, 293, 782 Mitchell CA, 879 Whitby M, 341, 780 Mitchell H, 764 Quinlan MF, 251 Stanley D, 353 Whyte G, 43 Mitchell JD, 723 Quong GG, 16, 489 Stepanas AV, 242 Wilkinson ML, 345 Mohamed KN, 290 Radford AJ, 230 Stewart AM, 230 Williams AJK, 888 Mond HG, 25 Ravenscroft PJ, 714 Stewart JF, 244 Williams BG, 447 Morris HA, 275 Reed WD, 47, 251, 783 Stewart JH, 693 Wilson A, 732 Morris JGL, 11, 82 Rivers JT, 879 Stiller KR, 78 Wilson F, 850 Moss JR, 217 Roberts L, 780 Stock H, 681 Wilton NM, 491 Morrison RBI, 29 Roder D, 65 Strakosch CR, 248 Windom H, 753 Mossman S, 930 Roger SD, 22, 693 Street A, 747 Wing LMH, 397 Muller D, 325 Rolfe I, 235 Stuart-Harris RC, 857 Wing YK, 751 Munn §S, 884 Rolland J, 307 Sutherland DC, 222 Wolf MM, 16, 489 Murray B, 52 Rosenfeld JV, 477 Szanto A, 330 Wood G, 341, 780 Woodhouse S, 401 Musk AW, 460, 681 Rosenfeldt FL, 325 Szer J, 43, 408, 686 Wrigley C, 222 Nagaratnam N, 381 Rosenthal MA, 857 Tandon MK, 427 Yiannikas C, 11 Nankivell BJ, 414 Ross DL, 239 Tannenberg AEG, 379 Yip M-Y, 55 Nash P, 737 Rowlings PA, 52, 55 Thomas MG, 442 York HF, 710 Naughton M, 833, 917 Rozenberg MC, 52, 55 Thompson PJ, 871 Young GAR, 246, 447 Neale TJ, 29 Ruhno J, 222 Thompson TJ, 29 Young GD, 444 Need AG, 275, 488 Russell D, 487 Thomson DB, 835 Young S, 850 Ng K, 886 Ryan G, 681 Thomson K, 902 Zagami AS, 350 Ng SC, 772 Sallie RW, 251 Thorburn C, 451 Zeng GE, 211 INDEX TO AUTHORS —- VOL. 21; 1991 Subject Index to Volume 21 Aboriginal children, Australian, nutrition and infections in, 921 Aspirin, effects of, on the healing of duodenal ulcer, ethical aspects Aborigine, adult T-cell leukaemia lymphoma in an, 739 of a study of (Letter), 80 Actinomycosis, pulmonary, complicated by effusive constrictive Asterixis with carbamazepine toxicity, complete external pericarditis, 879 ophthalmoplegia and, 886 Adenocarcinoma, pancreatic, responding to cisplatin based cytotoxic Asthma Campaign, the National — a measurable public health chemotherapy (Letter), 780 exercise (Editorial), 4 AIDS, invasive aspergillosis in, 747 Asthma deaths: where are we now? (Editorial), 678 Alpha 1-antitrypsin deficiency and pancreatitis in a juvenile, 345 Asthma, risk factors for death in patients admitted to hospital with: Alpha thalassaemia and hereditary spherocytosis, concurrence of, 485 a follow-up study, 681 Alpha-2b interferon, recombinant, in patients with malignant Asthma mortality and inhaled beta agonist therapy, 753 carcinoid tumour, 875 Atrioventricular junction ablation, direct-current shock, ventricular Alpha-interferon, relief of itch associated with myeloproliferative dysfunction following, 25 disease by (Letter), 81 Autoantibodies in systemic vasculitis, 433 Amyloid arthropathy of the shoulder, spontaneous haemarthrosis Azathioprine and cyclosporin in refractory rheumatoid arthritis, in, 343 randomised double blind trial of, 844 Anaemia, severe aplastic, cyclosporin associated remission (Letter), 292 Angioplasty, coronary, emergency coronary artery bypass surgery Barmah Forest polyarthritis, acute, 737 following — favourable medium term outcome after eight years’ Beta agonist, inhaled, therapy, asthma mortality and, 753 experience, 211 Biochemical and molecular investigation of mitochondrial disease: Anti-GBM antibody-mediated disease, human, inability to detect an illustrative case showing the value of a multifaceted approach, circulating anti-idiotypic antibodies in, using a splenic PFC assay, 837 36 Bipolaris and Curvularia, allergic bronchopulmonary fungal disease Anti-gliadin antibodies in serum, enzyme-linked immunosorbent caused by, 871 assay to detect: a reliable screening test for coeliac disease, 723 Blood pressure and body mass index in obstructive sleep apnoea, Anti-idiotypic antibodies, circulating, in human anti-GBM antibody- effects of nasal continuous positive airway pressure on, 917 mediated disease, inability to detect, using a splenic PFC assay, 36 Bone marrow transplantation, allogeneic, GM-CSF after: accelerated Antibodies, antiphospholipid, 463 recovery of neutrophils, monocytes and lymphocytes, 686 Antibodies, circulating anti-idiotypic, in human anti-GBM antibody- Bone marrow transplantation, allogeneic, from histocompatible mediated disease, inability to detect, using a splenic PFC assay, 36 sibling donors, chronic myeloid leukaemia treated by — an Antibodies, anti-gliadin, in serum, enzyme-linked immunosorbent invariably fatal malignancy rendered highly curable, 408 assay to detect: a reliable screening test for coeliac disease, 723 Bromocriptine therapy, retroperitoneal fibrosis, skin and pleuropul- Antiphospholipid antibodies, 463 monary changes associated with (Letter), 82 Antithrombin III deficiency, cerebral venous thrombosis associated Bronchospasm, frusemide antagonises exercise-induced but not with, 772 histamine-induced, 7 Antithymocyte-globulin and corticosteroid therapy, response to: trans- fusion associated graft-versus-host disease after cardiac surgery, 43 Apnoea, sleep: contribution to the road toll (Editorial), 833 Calcium and osteoporosis, 275 Apnoea, obstructive sleep, differences in the symptoms of men and Calcium, osteoporosis and (Letter), 488 women with, 863 Cancer prevention in Australia, the potential for, 764 Apnoea, obstructive sleep, effects of nasal continuous positive airway Cancer, colorectal, what is the risk of developing? — ulcerative colitis, pressure on blood pressure and body mass index in, 917 71 Apnoea, obstructive sleep, long-term nasal CPAP does not ameliorate, Carbamazepine toxicity, complete external ophthalmoplegia and 235 asterixis with, 886 Apo A-I and coronary artery disease, high density lipoproteins, genetic Carbidopa/levodopa, controlled release, (Sinemet CR4), in polymorphism for, 330 Parkinson’s disease — an open evaluation of efficacy and safety, Apomorphine injection, intermittent subcutaneous, treatment for 397 Parkinsonian motor oscillations, 314 Carcinoid tumour, malignant, recombinant alpha-2b interferon in Arrhythmogenic right ventricular dysplasia, 451 patients with, 875 Arteritis, giant cell, associated with pericarditis and large vessel Carcinoma, transitional cell, of the renal pelvis, complete response disease, 353 of a, to leucovorin/5 fluorouracil chemotherapy, 244 Arteritis, giant cell, in two Chinese patients, 751 Cardiac papillary fibroelastomas, multiple, and rheumatic heart Arteritis, giant cell, ophthalmoplegia and (Letter), 930 disease, 744 Artery, left main coronary, spontaneous dissection of the: case report Cardiac surgery, transfusion associated graft-versus-host disease after: and review of the literature, 891 response to antithymocyte-globulin and corticosteroid therapy, 43 Arthropathy, amyloid, of the shoulder, spontaneous haemarthrosis Cardiac surgery, painful sciatic neuropathy following, 732 in, 343 ‘Cardiomyopathy’, permanent junctional reciprocating tachycardia Arthur E. Mills Oration, the — self-regulation and the professions: misdiagnosed as, 239 continuing legal education and regulating the regulators, 774 Cardiovascular and sociological risk factors at entry: Dubbo study Aspergillosis, invasive, in AIDS, 747 of the elderly, 701 Aspirin concurrently administered with ranitidine does not delay Castleman’s disease, POEMS syndrome and osteosclerotic myeloma: healing of duodenal ulcer (Letter), 80 a case report, 454 SUBJECT INDEX — VOL. 21, 1991 973 Cerebral infarction, progressive: Kohlmeier-Degos disease, a CPAP machines, nasal, problems with (Letter), 291 multisystem vasculopathy with, 49 Cronkhite-Canada syndrome associated with peripheral neuropathy Cerebral venous thrombosis associated with antithrombin III (Letter), 379 deficiency, 772 Cryofribrinogenaemia: a case report, 444 Cerebral artery infarction, right anterior, post-hemiplegic dystonia Crystals, reproducibility of synovial fluid examination for, 710 following (Letter), 381 Curvularia and Bipolaris, allergic bronchopulmonary fungal disease Cerebrospinal fluid, monoclonal immunoglobulin bands in the, 227 caused by, 871 Cerebrovascular accident, left, inability to cough voluntarily following Cutaneous lymphoma, an unusual, with B and T cell characteristics a, 78 showing gallium-67 positive benign thymic hyperplasia following Chemotherapy, cytotoxic, cisplatin based, pancreatic adenocarcinoma intensive chemotherapy, 447 responding to (Letter), 780 Cyclosporin A and mefenamic acid in a renal transplant patient Chemotherapy, intensive, an unusual cutaneous lymphoma with B (Letter), 784 and T cell characteristics showing gallium-67 positive benign Cyclosporin associated remission in severe aplastic anaemia (Letter), thymic hyperplasia following, 447 292 Chinese patients, two, giant cell arteritis in, 751 Cyclosporin and azathioprine in refractory rheumatoid arthritis, Chinese, pathology of fatal acute myocardial infarction in the (Letter), randomised double blind trial of, 844 82 Cyclosporin and methotrexate versus cyclosporin, methotrexate and Cholesterol, screening and intervention for (Editorial), 393 prednisolone for prevention of graft-versus-host disease after Cholesterol reduction, oat bran and: evidence against specific effect, HLA-identical sibling marrow transplantation for haematological 422 malignancy, a prospective randomised trial oi, 850 Cholesterol emboli, renal failure due to, 418 Cytochromes P450, human hepatic, role of, in drug metabolism and Chorioretinitis as a possible very early manifestation of subacute toxicity, 356 sclerosing panencephalitis, 350 Cytotoxic chemotherapy, cisplatin based, pancreatic adenocarcinoma Chronic bronchitis, acute exacerbations of, a controlled trial of a responding to (Letter), 780 killed Haemophilus influenzae vaccine for prevention of, 427 Chronic myeloid leukaemia treated by allogeneic bone marrow trans- plantation from histocompatible sibling donors — an invariably Dantrolene, intravenous, fulminant metoclopramide induced fatal malignancy rendered highly curable, 408 neuroleptic malignant syndrome rapidly responsive to, 742 Cisplatin based cytotoxic chemotherapy, pancreatic adenocarcinoma Diabetes mellitus, Type 2 (non-insulin dependent), metformin responding to (Letter), 780 increases insulin sensitivity and basal glucose clearance in, 714 Coeliac plexus blockade, more complications of (Letter), 782 Diabetes mellitus and pancreatitis, pentamidine induced, survival Coeliac disease, a reliable screening test for: enzyme-linked from, 341 immunosorbent assay to detect anti-gliadin antibodies in serum, Diabetes mellitus and optic disc oedema: a case report with review, 723 248 Coeliac disease and epidermolysis bullosa acquisita, circulating anti- Diabetic end stage renal failure — the Wellington experience glomerular basement membrane antibodies in, 867 1975-1988, 29 Coeliac plexus block — diarrhoea, an unrecognised hazard of, 47 Diarrhoea — an unrecognised hazard of coeliac plexus block, 47 Colonoscopy, a randomised blinded study in colonic lavage for, 769 Diclofenac hepatitis, 251 Colorectal cancer, what is the risk of developing? — ulcerative colitis, Drug metabolism and toxicity, role of human hepatic cytochromes 71 P450 in, 356 Constipation, severe, as the presenting complaint of phaeochromo- Drug, multi-, resistant tuberculosis in migrants, 457 cytoma, 888 Duodenal ulcer, ethical aspects of a study of the effects of aspirin Continuous positive airway pressure (CPAP), long-term nasal, does on the healing of (Letter), 80 not ameliorate obstructive sleep apnoea, 235 Duodenal ulcer, aspirin concurrently administered with ranitidine Continuous positive airway pressure (CPAP), nasal, problems with does not delay healing of (Letter), 80 (Letter), 291 Dystonia, post-hemiplegic, following right anterior cerebral artery Coronary care unit, screening for hypercholesterolaemia in a (Letter), infarction (Letter), 381 931 Coronary heart disease, high density lipoproteins and (Editorial), 299 Coronary artery disease and apo A-I, high density lipoproteins, Elderly, Dubbo study of the: sociological and cardiovascular risk genetic polymorphism for, 330 factors at entry, 701 Coronary care unit, physician response to screening for hyper- Elderly patients, acutely ill, a defined group of, managed in a geriatric cholesterolaemia in, 401 assessment unit or a general medical unit, a randomised study Coronary angioplasty, emergency coronary artery bypass surgery of outcomes in, 230 following — favourable medium term outcome after eight years’ Empyema, salmonella, in a patient with lymphoma, 246 experience, 211 Endovascular infection, Sa/monella hadar, cure of, with medical Coronary artery bypass surgery, emergency, following coronary therapy, 442 angioplasty — favourable medium term outcome after eight years’ Eosinophilia and pulmonary infiltrates associated with sulphasalazine experience, 211 administration, 348 Corticosteroid and antithymocyte-globulin therapy, response to: trans- Epidemiological characteristics of Legionella infection in South fusion associated graft-versus-host disease after cardiac surgery, 43 Australia: implications for disease control, 65 Cotrimoxazole, Pneumocystis carinii pneumonia — upper lobe recur- Epidermolysis bullosa acquisita, circulating anti-glomerular basement rence following (Letter), 380 membrane antibodies in coeliac disease and, 867 Cough, chronic, an unusual case of (Letter), 780 Epilepsy, temporal lobe, sino-atrial arrest due to, 62 Cough voluntarily, inability to, following a left cerebrovascular Eruption, extensive fixed, to mefenamic acid (Letter), 290 accident, 78 Erythropoietin, low dose, in maintenance haemodialysis: CPAP, long-term nasal, does not ameliorate obstructive sleep apnoea, improvement in quality of life and reduction in true cost of 235 haemodialysis, 693 974 SUBJECT INDEX —- VOL. 21, 1991 Ethical aspects of a study of the effects of aspirin on the healing Hepatitis C, chronic active, can the response to interferon treatment of duodenal ulcer (Letter), 80 be predicted in patients with?, 387 Hepatitis, ischaemic . . . or hypoxic (Letter), 291 Hepatitis, diclofenac, 251 High density lipoproteins and coronary heart disease (Editorial), 299 Fibrosis, retroperitoneal, skin and pleuropulmonary changes High density lipoproteins, genetic polymorphism for apo A-I and associated with bromocriptine therapy (Letter), 82 coronary artery disease, 330 5-fluorouracil/leucovorin chemotherapy, complete response of a Histamine-induced bronchospasm, frusemide antagonises exercise- transitional cell carcinoma of the renal pelvis to, 244 induced but not, 7 Frusemide antagonises exercise-induced but not histamine-induced HIV positive patient, first and second complete remission in a, bronchospasm, 7 following remission induction therapy for acute non- Fungal disease, allergic bronchopulmonary, caused by Bipolaris and lymphoblastic leukaemia, 55 Curvularia, 871 Hodgkin’s disease, the place of gallium scanning is established in (Letter), 489 Hodgkin’s disease, infradiaphragmatic, long term follow-up of a rare presentation, 16 Gallium scanning, the place of, in Hodgkin’s disease is established Hypercalcaemia, lithium and (Editorial), 675 (Letter), 489 Hypercholesterolaemia in a coronary care unit, physician response Gallium-67 positive benign thymic hyperplasia following intensive to screening for, 401 chemotherapy, an unusual cutaneous lymphoma with B and T Hypercholesterolaemia in a coronary care unit, screening for (Letter), cell characteristics showing, 447 931 Gene, T cell receptor and immunoglobulin, rearrangement analysis Hypertension, managing (Letter), 290 as a laboratory aid in the diagnosis of human malignant Hypertension, pregnancy-induced: pathogenesis and management, lymphoproliferative diseases, 307 257 Genetic locus, a single, for adult polycystic kidney disease in five Hypoxic . . . or ischaemic hepatitis (Letter), 291 Australian families of southern European origin, 720 Genetic polymorphism, high density lipoproteins for apo A-I and coronary artery disease, 330 Geriatric assessment unit or general medical unit, a randomised study ‘Informatics, medical’— a bridge between the clinician and the of outcomes in a defined group of acutely ill elderly patients computer scientist (Letter), 781 managed in a, 230 Immune thrombocytopenia, targeted-immunosuppression with Giant cell arteritis, status epilepticus with (Letter), 931 vincristine infusion in the treatment of, 405 Giant cell arteritis in two Chinese patients, 751 Immunoglobulin and T cell receptor gene rearrangement analysis Giant cell arteritis associated with pericarditis and large vessel disease, as a laboratory aid in the diagnosis of human malignant 353 lymphoproliferative diseases, 307 GM-CSF after allogeneic bone marrow transplantation: accelerated Immunoglobulin bands, monoclonal, in the cerebrospinal fluid, 227 recovery of neutrophils, monocytes and lymphocytes, 686 Immunosuppression, targeted-, with vincristine infusion in the Graft-versus-host disease after HLA-identical sibling marrow trans- treatment of immune thrombocytopenia, 405 plantation for haematological malignancy, a prospective Infarction, progressive cerebral: Kohlmeier-Degos disease, a randomised trial of cyclosporin and methotrexate versus multisystem vasculopathy with, 49 cyclosporin, methotrexate and prednisolone for prevention of, 850 Infarction, cerebral artery, right anterior, post-hemiplegic dystonia Graft-versus-host disease, transfusion associated, after cardiac surgery: following (Letter), 381 response to antithymocyte-globulin and corticosteroid therapy, 43 Infections in Australian Aboriginal children, nutrition and, 921 Informatics, medical — an Australian perspective, 363 Infradiaphragmatic Hodgkin’s disease, long term follow-up of a rare presentation, 16 Haemangiopericytoma, meningeal, hepatic metastasis from a, 884 Insulin sensitivity and basal glucose clearance in Type 2 (non-insulin Haemarthrosis, spontaneous, in amyloid arthropathy of the shoulder, dependent) diabetes mellitus, metformin increases, 714 343 Interferon treatment, can the response be predicted in patients with Haematological malignancy, HLA-identical sibling marrow trans- chronic active hepatitis C?, 387 plantation for, a prospective randomised trial of cyclosporin and Interferon, recombinant alpha-2b, in patients with malignant methotrexate versus cyclosporin, methotrexate and prednisolone carcinoid tumour, 875 for prevention of graft-versus-host disease after, 850 Interventional radiology — a review 902 Haemodialysis patients, hepatitis C virus infection in, 22 Intoxication, accidental or deliberate, ‘superwarfarins’ as agents of Haemodialysis, maintenance, low dose erythropoietin in: (Letter), 491 improvement in quality of life and reduction in true cost of Ischaemic . . . or hypoxic hepatitis (Letter), 291 haemodialysis, 693 H philus infl , a killed, vaccine for prevention of acute exacerbations of chronic bronchitis, a controlled trial of, 427 Kidney disease, adult polycystic, a single genetic locus for, in five Heparin dependent thrombocytopenia and thrombosis, the use of Australian families of southern European origin, 720 a low molecular weight heparinoid (Org 10172) for extracorporeal Kohlmeier-Degos disease: a multisystem vasculopathy with procedures in patients with, 52 progressive cerebral infarction, 49 Heparinoid, low molecular weight (Org 10172), the use of a, for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis, 52 Hepatic metastasis from a meningeal haemangiopericytoma, 884 Lambie-Dew Oration, the, 281 Hepatic cytochromes P450, human, role of, in drug metabolism and Laser, Nd-Yag, endoscopic therapy, successful treatment of two toxicity, 356 patients with gastric antral vascular ectasia ‘watermelon stomach’, Hepatitis C virus infection in haemodialysis patients, 22 439 SUBJECT INDEX — VOL. 21, 1991 975 Legal education, continuing, and regulating the regulators: self- Mydriasis, accidental, due to Prantal powder® (Letter), 929 regulation and the professions. The Arthur E. Mills Oration, 774 Myeloproliferative disease, relief of itch associated with, by alpha- Legionella infection in South Australia, epidemiological charac- interferon (Letter), 81 teristics of: implications for disease control, 65 Myocardial infarction, acute, the early diagnosis of, 335 Leiomyosarcoma, primary, of the heart: a rare cause of obstruction Myocardial infarction, fatal acute, in the Chinese, pathology of of the left ventricular outflow tract, 879 (Letter), 82 Leucovorin/5-fluorouracil chemotherapy, complete response of a transitional cell carcinoma of the renal pelvis to, 244 Leukaemia, chronic myeloid, treated by allogeneic bone marrow Nasal CPAP machines, problems with (Letter), 291 transplantation from histocompatible sibling donors — an National Asthma Campaign, the — a measurable public health invariably fatal malignancy rendered highly curable, 408 exercise (Editorial), 4 Leukaemia, acute non-lymphoblastic, first and second complete Nd-Yag laser therapy, endoscopic, successful treatment of two remissions in a HIV positive patient following remission therapy patients with gastric antral vascular ectasia ‘watermelon stomach’ for, 55 using, 439 Leukaemia lymphoma, adult T-cell, in an Aborigine, 739 Necrobacillosis — primary anaerobic septicaemia (Letter), 381 Levodopa/carbidopa, controlled release, (Sinemet CR4), in Nephrotic syndrome, renal sodium retention in, 893 Parkinson’s disease — an open evaluation of efficacy and safety, Neural transplantation for Parkinson’s disease: a critical appraisal, 477 397 Neuroleptic malignant syndrome, fulminant metoclopramide Lipoproteins, high density, and coronary heart disease (Editorial), 299 induced, rapidly responsive to intravenous dantrolene, 742 Lipoproteins, high density, genetic polymorphism for apo A-I and Neuropathy, peripheral, phenelzine associated — clinical and coronary artery disease, 330 electrophysiologic findings, 339 Lithium and hypercalcaemia (Editorial), 675 Neuropathy, peripheral, Cronkhite-Canada syndrome associated with Low molecular weight heparinoid (Org 10172), the use of a, for extracorporeal procedures in patients with heparin dependent (Letter), 379 thrombocytopenia and thrombosis, 52 Neuropathy, painful sciatic, following cardiac surgery, 732 Lymphoma, an unusual cutaneous, with B and T cell characteristics New Zealand, variation in vascular mortality in (Letter), 487 Non-seminomatous germ cell tumours of the testis: game and set showing gallium-67 positive benign thymic hyperplasia following but not match (Editorial), 835 intensive chemotherapy, 447 Nutrition and infections in Australian Aboriginal children, 921 Lymphoma, salmonella empyema in a patient with, 246 Lymphoproliferative diseases, human malignant, T cell receptor and immunoglobulin gene rearrangement analysis as a laboratory aid in the diagnosis of, 307 Oat bran and cholesterol reduction: evidence against specific effect, 422 Obstruction of the left ventricular outflow tract, primary leiomyosarcoma of the heart: a rare cause of, 881 Oesophageal intramural pseudodiverticulosis — always benign?, 58 Madopar, standard, and controlled release Madopar in Parkinson’s One swallow doth not summer make (Letter), 783 disease, a comparison of, 11 Ophthalmoplegia, complete external, asterixis with carbamazepine Marrow transplantation, HLA-identical sibling, for haematological toxicity, and, 886 malignancy, a prospective randomised trial of cyclosporin and Ophthalmoplegia, giant cell arteritis and (Letter), 930 methotrexate versus cyclosporin, methotrexate and prednisolone Optic disc oedema and diabetes mellitus: a case report with review, for prevention of graft-versus-host disease after, 850 248 Mefenamic acid and cyclosporin A in a renal transplant patient Osteoporosis and calcium, 275 (Letter), 784 Osteoporosis and calcium (Letter), 488 Mefenamic acid, extensive fixed eruption to (Letter), 290 OsteoPPPorosis — Prevention, Prevention and Prevention (Editorial), Meningeal haemangiopericytoma, hepatic metastasis from a, 884 205 Mesothelioma, malignant pleural, miliary spread of, without a Osteosclerotic myeloma, POEMS syndrome and Castleman’s disease: clinically identifiable pleural tumour, 460 a case report, 454 Metastasis, hepatic, from a meningeal haemangiopericytoma, 884 Oxygen therapy, home: an audit of survival, 217 Metformin increases insulin sensitivity and basal glucose clearance in Type 2 (non-insulin dependent) diabetes mellitus, 714 Methotrexate and cyclosporin versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after Pancreatic adenocarcinoma responding to cisplatin based cytotoxic HLA-identical sibling marrow transplantation for haematological chemotherapy (Letter), 780 malignancy, a prospective randomised trial of, 850 Pancreatitis, acute, and rhabdomyolysis: a new association, 414 Metoclopramide induced neuroleptic malignant syndrome, fulminant, Pancreatitis and alpha 1-antitrypsin deficiency in a juvenile, 345 rapidly responsive to intravenous dantrolene, 742 Pancreatitis and diabetes mellitus, pentamidine induced, survival Miconazole oral gel, potentiation of warfarin action by (Letter), 928 from, 341 Migrants, multi-drug resistant tuberculosis in, 457 Panencephalitis, subacute sclerosing, chorioretinitis as a possible very Mitochondrial disease, biochemical and molecular investigation of: early manifestation of, 350 an illustrative case showing the value of a multifaceted approach, Parkinson’s disease, a comparison of standard Madopar and controlled 837 release Madopar in, 11 Molecular and biochemical investigation of mitochondrial disease: Parkinson’s disease, neural transplantation for: a critical appraisal, 477 an illustrative case showing the value of a multifaceted approach, Parkinson’s disease, controlled release levodopa/carbidopa (Sinemet 837 CR4) in — an open evaluation of efficacy and safety, 397 Mortality, vascular, in New Zealand, variation in (Letter), 487 Parkinsonian motor oscillations, intermittent subcutaneous apo- Motor oscillations, Parkinsonian, intermittent subcutaneous apo- morphine injection treatment for, 314 morphine injection treatment for, 314 Pentamidine induced pancreatitis and diabetes mellitus, survival Musculo-skeletal examination, the: a neglected clinical skill, 303 from, 341 976 SUBJECT INDEX —- VOL. 21, 1991 Pericarditis, effusive constrictive, pulmonary actinomycosis com- Sino-atrial arrest due to temporal lobe epilepsy, 62 plicated by, 879 Sleep apnoea, obstructive, long-term nasal CPAP does not ameliorate, Pericarditis and large vessel disease, giant cell arteritis associated 235 with, 353 Sociological and cardiovascular risk factors at entry: Dubbo study Phaeochromocytoma, severe constipation as the presenting complaint of the elderly, 701 of, 888 Sodium retention, renal, in the nephrotic syndrome, 893 Phenelzine associated peripheral neuropathy — clinical and South Australia, epidemiological characteristics of Legionella electrophysiologic findings, 339 infection in: implications for disease control, 65 Plaque-forming cell assay, splenic, inability to detect circulating anti- Southern European origin, five Australian families of, a single genetic idiotypic antibodies in human anti-GBM antibody-mediated locus for adult polycystic kidney disease in, 720 disease using a, 36 Spherocytosis, hereditary, and alpha thalassaemia, concurrence of, Pleuropulmonary and skin changes, retroperitoneal fibrosis associated 485 with bromocriptine therapy (Letter), 82 Spontaneous dissection of the left main artery: case report and review Pneumocystis carinii pneumonia — upper lobe recurrence following of the literature, 891 cotrimoxazole (Letter), 380 Status epilepticus, giant cell arteritis with (Letter), 931 Pneumonia, Pneumocystis carinii — upper lobe recurrence following Subacute sclerosing panencephalitis, chorioretinitis as a possible very cotrimoxazole (Letter), 380 early manifestation of, 350 POEMS syndrome, osteosclerotic myeloma and Castleman’s disease: Sulphasalazine administration, pulmonary infiltrates and eosinophilia a case report, 454 associated with, 348 Polyarthritis, acute Barmah Forest, 737 ‘Superwarfarins’ as agents of accidental or deliberate intoxication Prantal powder® , accidental mydriasis due to (Letter), 929 (Letter), 491 Prednisolone, cyclosporin and methotrexate versus methotrexate and Synovial fluid examination for crystals, reproducibility of, 710 cyclosporin for prevention of graft-versus-host disease after HLA- identical sibling marrow transplantation for haematological malig- nancy, a prospective randomised trial of, 850 Pregnancy-induced hypertension: pathogenesis and management, 257 T and B cell characteristics, an unusual cutaneous lymphoma with, Pseudodiverticulosis, oesophageal intramural — always benign?, 58 showing gallium-67 positive benign thymic hyperplasia following Public health exercise, a measurable — the National Asthma intensive chemotherapy, 447 Campaign (Editorial), 4 T cell receptor and immunoglobulin gene rearrangement analysis Pulmonary actinomycosis complicated by effusive constrictive as a laboratory aid in the diagnosis of human malignant pericarditis, 879 lymphoproliferative diseases, 307 Pulmonary infiltrates and eosinophilia associated with sulphasalazine Tachycardia, permanent junctional reciprocating, misdiagnosed as administration, 348 ‘cardiomyopathy’, 239 Targeted-i ppression with vincristine infusion in the treatment of immune thrombocytopenia, 405 Temporal lobe epilepsy, sino-atrial arrest due to, 62 Radiology, interventional — a review, 902 Testis, non-seminomatous germ cell tumours: game and set but not Ranitidine, concurrently administered with aspirin, does not delay match (Editorial), 835 healing of duodenal ulcer (Letter), 80 Testis, non-seminomatous germ cell tumours, single institutional Recombinant alpha-2b interferon in patients with malignant carcinoid experience with: local perspectives on a curable cancer, 857 tumour, 875 Thalassaemia, alpha, and hereditary spherocytosis, concurrence of, Regulation, self-, and the professions: continuing legal education and 485 regulating the regulators. The Arthur E. Mills Oration, 774 The way we live now (Editorial), 1 Remission induction therapy for acute non-lymphoblastic leukaemia, Thrombocytopenia, immune, targeted-i ppression with first and second complete remissions in a HIV patient following, vincristine infusion in the treatment of, 405 55 Thrombocytopenia and thrombosis, heparin dependent, the use of Renal failure, diabetic end stage — the Wellington experience a low molecular weight heparinoid (Org 10172) for extracorporeal 1975-1988, 29 procedures in patients with, 52 Renal sodium retention in the nephrotic syndrome, 893 Thrombosis, cerebral venous, associated with antithrombin III Renal pelvis, complete response of a transitional cell carcinoma of deficiency, 772 the, to leucovorin/5 fluorouracil chemotherapy, 244 Thrombosis and thrombocytopenia, heparin dependent, the use of Renal transplant patient, cyclosporin A and mefenamic acid in a a low molecular weight heparinoid (Org 10172) for extracorporeal (Letter), 784 procedures in patients with, 52 Renal failure due to cholesterol emboli, 418 Thymic hyperplasia, gallium-67 positive benign, following intensive Respiratory disease, wheat dust-associated, in a farming community, chemotherapy, an unusual cutaneous lymphoma with B and T 222 cell characteristics showing, 447 Rhabdomyolysis, acute pancreatitis and: a new association, 414 Transfusion associated graft-versus-host disease after cardiac surgery: Rheumatic heart disease, multiple cardiac papillary fibroelastomas response to antithymocyte-globulin and corticosteroid therapy, 43 and, 744 Transitional cell carcinoma of the renal pelvis, complete response Rheumatoid arthritis, refractory, a randomised double blind trial of a, to leucovorin/5 fluorouracil chemotherapy, 244 of cyclosporin and azathioprine in, 844 Transplant patient, renal, cyclosporin A and mefenamic acid in a Road toll, sleep apnoea’s contribution to the (Editorial), 833 (Letter), 784 Transplantation, neural, for Parkinson’s disease: a critical appraisal, 477 Salmonella empyema in a patient with lymphoma, 246 Transplantation, allogeneic bone marrow, from histocompatible Salmonella hadar endovascular infection, cure of, with medical sibling donors, chronic myeloid leukaemia treated by — an therapy, 442 invariably fatal malignancy rendered highly curable, 408 Sciatic neuropathy, painful, following cardiac surgery, 732 Transplantation, allogeneic bone marrow, GM-CSF after: accelerated Septicaemia, primary anaerobic - necrobacillosis (Letter), 381 recovery of neutrophils, monocytes and lymphocytes, 686 SUBJECT INDEX —- VOL. 21, 1991 977 Transplantation, HLA-identical sibling marrow, for haematological Vincristine infusion in the treatment of immune thrombocytopenia, malignancy, a prospective randomised trial of cyclosporin and targeted-immunosuppression with, 405 methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after, 850 Tuberculosis, multi-drug resistant, in migrants, 457 Warfarin treatment, standardised initial: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin Ulcerative colitis — what is the risk of developing colorectal cancer?, response, 319 71 Warfarin action, potentiation of, by miconazole oral gel, 928 Warfarin action by miconazole oral gel, potentiation of, 928 ‘Watermelon stomach’, gastric antral vascular ectasia, successful Vascular mortality in New Zealand, variation in (Letter), 487 treatment of two patients with, using endoscopic Nd-YAG laser Vascular ectasia, gastric antral, ‘watermelon stomach’, successful therapy, 439 treatment of two patients with, using endoscopic Nd-YAG laser Wellington experience 1975-1988, the — diabetic end stage renal therapy, 439 failure, 29 Vasculitis, systemic, autoantibodies in, 433 Wheat dust-associated respiratory disease in a farming community, Vasculopathy, a multisystem, with progressive cerebral infarction: 222 Kohlmeier-Degos disease, 49 Wolff-Parkinson-White syndrome, early and late results of surgery Ventricular outflow tract, left, primary leiomyosarcoma of the heart: for, 325 a rare cause of obstruction of the, 881 Ventricular dysfunction following direct-current shock atrio- ventricular junction ablation, 25 Ventricular dysplasia, arrhythmogenic right, 451 XY female athlete with Olympic potential, 242 SUBJECT INDEX - VOL. 21, 1991 Author Index to Proceedings of Special Societies — Volume 21 *Presenters are asterisked. Abbati D, 624, 626* Angus JA, 549 Bailey BP, 513 (four), 514 Beattie L, 611 Abbott D, 811*, 822* Angus PW, 569, 588 (two), 518, 532, 533, 535 Beeney LJ, 794*, 827 Abbott GD, 136 Angus-Leppan H, 602*, 612* (three) Begley CG, 129*, 159, 942*, Abdool I, 594 Anstey NM, 591* Bailey DL, 630 943 Abernethy MJ, 531, 555* Anthony JC, 173 Bailey RR, 135, 516 Begley G, 937, 938 Abeywardena MY, 624 Anthony M, 172*, 602* Bailly D, 122 Beilby J, 819 Ablett G, 145 Antic R, 644, 668 Bainbridge RM, 643 Beilin LJ, 516* Abramson M, 650*, 650, 668, Antico V, 640 Baird A, 599*, 603, 631 Bell AJ, 542 670 Antonino A, 629 Baird RW, 588, 594* Bell CJ, 565*, 571* Ackery D, 524 Antonio M, 534 Baker BW, 136* Bell D, 944 Adams JM, 948 Antoniou D, 565 Baker G, 646* Bell JM, 594, 595 Adena MM, 165 Antony G, 113 Baker J, 831 Bell MC, 196* Adler JS, 183 Antony JH, 174 Baker JJ, 940 Bell SC, 653*, 655* Agar NS, 957* Anvari M, 559* (four), 560* Baker MS, 563, 566, 579* Bellen JC, 629 Agrawal SK, 506 Baker R, 573, 961* Bellomo R, 651*, 658 Apicella C, 670* Ahern M, 187, 191, 195 Baldas J, 628 Bellon MS, 631 Aranki SF, 523 Ahuja GK, 201 Baldwin J, 802, 806*, 821, Belushkina NN, 509 Arbor A, 194 Aitken PM, 101 827*, 829 (two) Benatar SR, 664 Archer JR, 187 Akdeniz A, 793, 814 Balemi A, 671 Bendall LJ, 142, 955 Akkermans LMA, 560, 572, Ardakani B, 617 Ballantyne CL, 189 Beng C, 108* 578 Arkles B, 192 Ballard FJ, 564 Benjelloun H, 523 Al-Aska AK, 203 Arkles LB, 623 Bananis T, 164 Bennett A, 942 Al-Noza M, 203 Armour CL, 647 Bannister KM, 631*, 633* Bennett H, 173, 608 Al-Orainey IA, 203 Armstrong JMcD, 188 Ea:din PG, 647 Bennett N, 825* Alexander T, 811, 826, 827 Armstrong L, 646 Barker G, 547 (two) Bennett P, 194 Alexeyeff M, 564 Armstrong M, 963 Barlow AJ, 556* Bennett SI, 517 Alford FP, 99, 100, 101, 114, Armstrong S, 196 Barnden LR,624* Benson E, 543 792, 793, 807, 813, 817, Arnold B, 134 Barnes RK, 623 Bentley JS, 639* 818, 831 Arnold JMO, 537 Barnett LD, 798 Beran RG, 618, 620*, 621 Alford J, 108* Arnold M, 188 Barnett M, 808* Berbari EJ, 505 Allan RM, 521, 522 (three) Arnold R, 121 Baron D, 543 548 Berend N, 662, 665, 670, Allen DH, 655 Arnott J, 648* Barr TJ, 669, 674 670* Allen J, 581 Aroney CN, 510*, 510, 529 Barter P, 529 Beretov J, 811* Allen JR, 160 Arthur CK, 157, 160, 939, Bartholomeusz RK, 113* Berger H, 152 Allen P, 92 946, 947 Barton H, 629* Bergin B, 549 Allen R, 108 Asbahr H, 949, 953 Bartrop R, 520 Bergin P, 530, 543 Allen RDM, 805* Ashwell S, 120, 795 Bashford J, 139, 951* Berkovic SF, 166*, 177*, Allen RJ, 561* Atchison M, 192 Basic D, 536, 544*, 582* 178*, 616, 620 (two), 632 Allen RKA, 652* Atkins RC, 673 Basile S, 582 Berman DS, 624 Allen RM, 645* Atkinson K, 154, 945, 949, Baskin D, 791 Berman K, 570 Allen S , 508 951, 952 Bass N, 555 Berndt MC, 139* (two), 142, Allen TJ, 96, 104, 793, 793*, Basten A, 493* 955, 959, 964* Attwood PV, 137 798, 814 Batch JA, 114 Berney N, 830*, 831* Au-Yeung D, 138 Allman K, 625 (two) Batchelor F, 581 Bernstein L, 518, 535 (two) Aumann H, 962 Alouan L, 647 Bateman ED, 664 Bertoncello I, 949* Austin MC, 599, 631, 632 Alpers JH, 657 (two), 671 Batey R, 568 (two), 569*, 574, Besser M, 610 Alvarez J, 520 Avalos BR, 949 577 Best JD, 95*, 99, 100, 792*, Amerena J, 528 Avolio A, 526, 527 Bauman A, 644*, 645, 650* 813 Amis T, 667 Axelsen RA, 576 Bautovich GJ, 518, 519, 623, Bestak R, 535 Amlot P, 188 Ayers B, 831* 625, 638 Bett JHN, 510, 529 Anderson CS, 165*, 166*, Ayling E, 638 Baxley WA, 506 Better N, 623*, 625* 493* Aylward PEG, 540 Baxter AG, 113* Bettridge DB, 142 Anderson KP, 546 Azhar A, 816 Baxter RC, 114, 799*, 809, Betts WH, 509* Anderson N, 197 812 Beynon S, 797 Anderson SD, 644, 670 Baan K, 638 Bayliss C, 187 Beyreuther K, 172 Andrew JH, 595 Bacelj A, 91* Beard MEJ, 136, 155*, 160*, Bhathal PS, 561 Andrews JT, 574, 632 Bach LA, 91, 795, 803, 814 947 Bhatia K, 202 (two) Andrews M, 549 Bacigalupo A, 160 Beasley R, 644, 650, 658, 659, Bhattacharya S, 152 Andrikopoulos S, 99*, 808* Bacon B, 644 661 Bibbo G, 626*, 627 AUTHOR INDEX TO PROCEEDINGS OF SPECIAL SOCIETIES — VOL. 21; 1991 Bickley J, 566 Bowen JA, 941 Brown P, 97, 810 Campbell L, 120, 125, 145 Biddle M, 122, 126, 820* Bowen K, 200 Brown RD, 134*, 135, 146 Campbell LJ, 943, 967* Biegler B, 655 Bowen KM, 811 (two), 147* (two), 938* Campbell LV, 100, 795*, 806, Biggs JC, 154, 945, 949 (two), Bower C, 550* (two), 941 (two), 956 807 951 (two), 952 (three) Bower GD, 649 Brown RIG, 507, 508 (four) Campbell SJ, 135 Bilkington G, 938 Bowes G, 643, 650, 654, 656, Brown T, 568 Campbell TJ, 505 Billson V, 92, 795 659, 668, 669, 670, 674 Bruce DG, 89, 585 Cannell PK, 141*, 144*, 157, Bilous RW, 115 Bowman RV, 672 Bruck K, 633 941 Bird C, 660 Boxall JA, 517, 518 Brumley J, 936 Cannon AD, 506* Bird DM, 806 Boyages S, 830 Brunker P, 582, 585 Cantrill E, 577 Bird PH, 95* Boyd AW, 194, 938, 960 Brusic H, 571 Carlin JB, 597 Birner R, 936 Boyd P, 537* Bryant D, 664 (two), 655* Carr RW, 617 Bishop A, 577 Boyd SJ, 639 Bryce JA, 517* Carroll G, 636 Bishop JF, 130, 153, 658, 659, Bradley BA, 161 Bryson J, 107* Carroll GJ, 192, 196 966 Bradley BM, 171 Bryson JM, 818* Carroll K, 963 Black IW, 521* (two), 522 Bradley J, 187 Buchanan JG, 155 Carroll N, 648, 663, 667, (three), 552* Bradley JA, 510 Buchanan N, 178 671*, 672*, Black JL, 173, 647* Bradley TR, 946 Buchanan RRC, 197, 201* Carroll WM, 167, 177, 184, Blacklock H, 149 Bradstock K, 939, 940, 951, Buckley M, 951 602, 612 Blackstone EH, 536 952 Buffery S, 622 Carter A, 824* Blackwell GG, 523 Brady PW, 653 Bull D, 123 Carter B, 523 Blackwell L, 643 Brancatisano A, 651, 667 Bunce I, 157, 948 Carter M, 550 Bladin CF, 176*, 183* Brand JC, 792, 805* Burdon J, 643*, 655* Cartmill TB, 534, 538 Bladin PF, 166, 178, 611, Brand-Maher CE, 136 Burgess C, 650, 658, 659, 644, Case C, 537 616, 620, 632 Branford AL, 158 661 Casey G, 132 (two) Blair A, 120, 125* Brasch JM, 937 Burgess TR, 115, 791 Casley D, 793 Blair SC, 797, 818 Brassat J, 647 Burgin M, 153 Cassidy, 493* Blake DR, 187 Braun J, 966 Burke C, 584, 611 Castaldi PA, 955 Blake DW, 537* Brawn WJ, 524 Burke D, 612 Caterson ID, 99, 103, 797, Blau G, 826 Brazier D, 610 Burke WM, 655, 664 808, 812, 818 (three) Blaufox MD, 493* Breaden A, 543 Burne JA, 613, 617, 622* Catovsky D, 935*, 950* Bleakley P, 579 Brealey J, 566 Burnet RB, 108*, 123 Caudwell J, 792, 811*, 813 Bleasel AF, 174 Breen KJ, 576 (two) Burns GF, 139, 194 (two) Blennerhassett JB, 158 Bremer JM, 107 Burns RJ, 621 Caughey DE, 189 Blight M, 659, 663 Bremner P, 644, 659, 661 Burns T, 569 Caust J, 658, 659 Block J, 164 Brenton W, 617 Burrow JN, 165* Cebon J, 114, 937 Bloomfield CD, 137*, 140* Breslin ABX, 575, 657, 662, Burry HC, 204* Cejnar M, 519*, 520 (two) Bloomfield P, 630 670 Burstow DJ, 510, 527 Center R, 943, 966 Blum P, 602 Bretland PM, 623*, 631*, Burvill PW, 165 Chakera T, 165 Blumbergs PC, 165, 166, 179 634* Butler RN, 565, 565* Challis DR, 956 (two), 603, 605, 615, 621 Brettell M, 154, 962 Butler SP, 637*, 639 Challis J, 943 (two) Blumer C, 196 Brew BJ, 615*, 618 Butler WJ, 565 Chalmers JP, 549 Bochner F, 509 Bridle TM, 624 Bye A, 177 Chamberlain A, 526, 581 Bogardus C, 91 Brieger DB, 513 (three), 513*, Bye AME, 503 Chambers BR, 175, 176 (two), Bohn D, 547 514 (two), 538* Byrne E, 163, 164, 182, 615 599, 612, 614, 615 Bolton AE, 940(two) Brighthope I, 597 Byrne G, 106, 122*, 126, 825 Chamley L, 195 Bolton T, 96 Brindle W, 626* Byth K, 183, 570 Chan FL, 600, 601 Bonadonna RC, 98 Brisco MJ, 129, 156*, 936 Chan K, 649 Bone C, 823 Broadbent B, 654 Caden MJ, 107*, 805* Chan YW, 601*, 613 Bonnem E, 938, 951 Broadhurst R, 554 (two) Cailes JB, 654* Chandler DC, 163 Bonney M, 796, 817* Brocklebank AM, 156 Cala LA, 173* Chang CM, 600, 606, 621* Bonnyman J, 628* Brodribb TR, 592 Cala SJ, 651*, 666* Chang L, 955 Boorman C, 119, 123, 127, Broe GA, 172 (two), Calafiore P, 539 (two), 540* Chang VP, 510, 511 (two), 827 173*(two), 608 (two), 540 512 (two), 543, 664 (two) Borkman M, 120, 807* Bronstein AM, 614 Calame J, 505 Chapman JR, 160*, 963* Botes D, 200 Brookes SHJ, 564 Calder AL, 542, 542* Chapple M, 160 Boundy KL, 166*, 179, 603*, Brookfield M, 123* Calligeros D, 816 Charalambous D, 959 603, 615*, 618* Brooks B, 803, 822, 825*, 827 Cameron DP, 806 Chard RB, 523, 546 Bourke JP, 541* (two), 546 Brooks PM, 193, 199 Cameron J, 510, 529, 530 Charles P, 940, 946 Bourne AJ, 603, 615 Brookwell R, 966 (two), 530* Charlton B, 91 Bourne G, 539* Brotodihardjo A, 574* Cameron PA, 644 Charnock JS, 624 Bournel AJ, 179 Broughton A, 549 Cameron-Smith D, 817* Chase C, 628 Boutagy J, 155 (two), 944 Browett PJ, 143, 146, 155 Campbell B, 529 Chatterton BE, 558, 573, 624, Boutin C, 547 Brown AH, 525 Campbell DA, 507, 657* 658 629, 632, 632*, 639* Bowden DK, 968 Brown D, 503 Campbell E, 122 Chauhan V, 528 Bowden F, 503 Brown JE, 556 Campbell H, 644 Chee K-Y, 503 * Bowden FJ, 593 Brown JM, 527 Campbell IL, 111 (two), 112, Chen C, 99*, 808*, 812 Bowden JJ, 648* Brown L, 831 113 Chen M, 171 980 AUTHOR INDEX TO PROCEEDINGS OF SPECIAL SOCIETIES — VOL. 21; 1991

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users